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SUMMARY
Background. Urinary tract infection (UTI) in the United States is
the most common bacterial infection, and urine cultures often
make up the largest portion of workload for a hospital-based mi-
crobiology laboratory. Appropriately managing the factors affect-
ing the preanalytic phase of urine culture contributes significantly
to the generation of meaningful culture results that ultimately
affect patient diagnosis and management. Urine culture contam-
ination can be reduced with proper techniques for urine collec-
tion, preservation, storage, and transport, the major factors affect-
ing the preanalytic phase of urine culture.
Published 23 November 2015
Citation LaRocco MT, Franek J, Leibach EK, Weissfeld AS, Kraft CS, Sautter RL,
Baselski V, Rodahl D, Peterson EJ, Cornish NE. 2016. Effectiveness of preanalytic
practices on contamination and diagnostic accuracy of urine cultures: a
laboratory medicine best practices systematic review and meta-analysis.
Clin Microbiol Rev 29:105–147. doi:10.1128/CMR.00030-15.
Address correspondence to Mark T. LaRocco, m.larocco@hotmail.com.
Copyright © 2015 LaRocco et al. This is an open-access article distributed under
the terms of the Creative Commons Attribution 3.0 Unported license.
CLINICAL MICROBIOLOGY BEST PRACTICES
crossmark
January 2016 Volume 29 Number 1 cmr.asm.org 105Clinical Microbiology Reviews
Objectives. The purposes of this review were to identify and
evaluate preanalytic practices associated with urine specimens
and to assess their impact on the accuracy of urine culture
microbiology. Specific practices included collection methods
for men, women, and children; preservation of urine samples
in boric acid solutions; and the effect of refrigeration on stored
urine. Practice efficacy and effectiveness were measured by two
parameters: reduction of urine culture contamination and in-
creased accuracy of patient diagnosis. The CDC Laboratory
Medicine Best Practices (LMBP) initiative’s systematic review
method for assessment of quality improvement (QI) practices
was employed. Results were then translated into evidence-
based practice guidelines.
Search strategy. A search of three electronic bibliographic da-
tabases (PubMed, SCOPUS, and CINAHL), as well as hand
searching of bibliographies from relevant information sources, for
English-language articles published between 1965 and 2014 was
conducted.
Selection criteria. The search contained the following medical
subject headings and key text words: urinary tract infections, UTI,
urine/analysis, urine/microbiology, urinalysis, specimen han-
dling, preservation, biological, preservation, boric acid, boric ac-
id/borate, refrigeration, storage, time factors, transportation,
transport time, time delay, time factor, timing, urine specimen
collection, catheters, indwelling, urinary reservoirs, continent,
urinary catheterization, intermittent urethral catheterization,
clean voided, midstream, Foley, suprapubic, bacteriological tech-
niques, and microbiological techniques.
Main results. Both boric acid and refrigeration adequately
preserved urine specimens prior to their processing for up to 24
h. Urine held at room temperature for more than 4 h showed
overgrowth of both clinically significant and contaminating
microorganisms. The overall strength of this body of evidence,
however, was rated as low. For urine specimens collected from
women, there was no difference in rates of contamination for
midstream urine specimens collected with or without cleans-
ing. The overall strength of this evidence was rated as high. The
levels of diagnostic accuracy of midstream urine collection
with or without cleansing were similar, although the overall
strength of this evidence was rated as low. For urine specimens
collected from men, there was a reduction in contamination in
favor of midstream clean-catch over first-void specimen col-
lection. The strength of this evidence was rated as high. Only
one study compared midstream collection with cleansing to
midstream collection without cleansing. Results showed no
difference in contamination between the two methods of col-
lection. However, imprecision was due largely to the small
event size. The diagnostic accuracy of midstream urine collec-
tion from men compared to straight catheterization or supra-
pubic aspiration was high. However, the overall strength of this
body of evidence was rated as low. For urine specimens col-
lected from children and infants, the evidence comparing con-
tamination rates for midstream urine collection with cleansing,
midstream collection without cleansing, sterile urine bag col-
lection, and diaper collection pointed to larger reductions in
the odds of contamination in favor of midstream collection
with cleansing over the other methods of collection. This body
of evidence was rated as high. The accuracy of diagnosis of
urinary tract infection from midstream clean-catch urine spec-
imens, sterile urine bag specimens, or diaper specimens com-
pared to straight catheterization or suprapubic aspiration was
varied.
Authors’ conclusions. No recommendation for or against is
made for delayed processing of urine stored at room temperature,
refrigerated, or preserved in boric acid. This does not preclude the
use of refrigeration or chemical preservatives in clinical practice. It
does indicate, however, that more systematic studies evaluating
the utility of these measures are needed. If noninvasive collection
is being considered for women, midstream collection with cleans-
ing is recommended, but no recommendation for or against is
made for midstream collection without cleansing. If noninvasive
collection is being considered for men, midstream collection with
cleansing is recommended and collection of first-void urine is not
recommended. No recommendation for or against is made for
collection of midstream urine without cleansing. If noninvasive
collection is being considered for children, midstream collection
with cleansing is recommended and collection in sterile urine
bags, from diapers, or midstream without cleansing is not recom-
mended. Whether midstream collection with cleansing can be
routinely used in place of catheterization or suprapubic aspiration
is unclear. The data suggest that midstream collection with cleans-
ing is accurate for the diagnosis of urinary tract infections in in-
fants and children and has higher average accuracy than sterile
urine bag collection (data for diaper collection were lacking);
however, the overall strength of evidence was low, as multivariate
modeling could not be performed, and thus no recommendation
for or against can be made.
INTRODUCTION
The most common infection occurring in the United States isurinary tract infection (UTI), accounting for nearly 7 mil-
lion office visits, 1 million emergency room visits, and 100,000
hospitalizations per year (1, 2). Significantly more women than
men are likely to experience UTIs, with 1 in 3 women having at
least 1 episode of UTI necessitating treatment with antibiotics
by the age of 24 (3). Nearly half of all women will experience at
least one UTI during their lifetime (3–6). An increased risk of
UTI occurs in certain population subgroups, including infants
(7), pregnant women (8), the elderly (9), patients with spinal
cord injuries and/or catheters (10), patients with diabetes (11)
or multiple sclerosis (12), and patients with AIDS/human im-
munodeficiency virus (13, 14). The most common nosocomial
infection is catheter-associated UTI, with over a million cases
in hospital and nursing home patients every year (15). Increas-
ing duration of catheterization increases the risk of infection
(16). Urinary tract infections are the second-most-common
infection in noninstitutionalized elderly populations and ac-
count for nearly 25% of all infections (9). The financial impact
of UTIs is significant, with costs of up to $2 billion per year
(17).
While many uncomplicated UTIs in outpatients are diagnosed
clinically, the diagnosis of recurrent or complicated UTI is com-
monly achieved by testing urine specimens for the presence of
microorganisms. As a result, urine cultures often make up the
largest portion of the workloads of clinical microbiology labora-
tories (18). The appropriate management of components of the
preanalytic phase of urine culture, namely, collection, preserva-
tion, and storage of urine specimens, has an important influence
LaRocco et al.
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on the generation of meaningful culture results, which ultimately
affects patient diagnosis and management (19).
Quality Gap: Factors Associated with the Preanalytic Phase
of Urine Culture
The major goal of proper specimen management is to ensure that
specimen quality is maintained during collection and transport
(20). Urine specimens can easily become contaminated with peri-
urethral, epidermal, perianal, and vaginal flora. This contamina-
tion can be reduced with proper attention to techniques for urine
collection, transport, preservation, and storage, the major compo-
nents of the preanalytic phase of urine culture. A Q-Probe study
conducted by the College of American Pathologists in 1998 (21)
and again in 2008 (22) examined the frequency of urine culture
contamination (defined as more than two isolates in quantities
greater than 10,000 CFU/ml) and associated facility practices of
urine collection and specimen management. Contamination rates
of 41.7% (low-performance facilities), 15% (median performers),
and 0.8% (high performers) correspond to the 10th, 50th, and
90th percentiles of facilities, respectively (22). Contamination
rates had no correlation to collection site, use of collection kits,
preservatives, or thermally insulated transport containers. How-
ever, contamination rates were substantially affected by postcol-
lection processing, especially refrigeration of the specimen. Also,
collection instructions given in the outpatient setting had a statis-
tically significant impact on contamination rates in some cases.
Based on the similarities of overall contamination rates between
the two Q-Probe studies, the authors concluded that no signifi-
cant progress in reducing urine culture contamination during the
intervening years had been made (22). This may be a reflection of
the inherent limitations of the Q-Probe methodology, which is
based on one-time quality assessments dependent on the gather-
ing of current data from large numbers of laboratories in order to
establish provisional benchmarks for systematic quality improve-
ment efforts. Many of these indicators are based primarily on self-
reported surveys rather than on evidence-based scientific study
designs and/or adequately specified, standardized, and consis-
tently implemented data collection methods. Nonetheless, it is not
cost-effective for laboratories to continue to waste valuable re-
sources on the work-up of contaminated urine cultures (23). Fur-
thermore, inappropriate reporting of contaminated urine cul-
tures by the laboratory can result in patients receiving suboptimal
or unnecessary therapy, producing poor patient outcomes and
higher cost (18).
To address this important quality gap and its consequences, this
research identified and evaluated practices associated with the col-
lection, preservation, and storage of urine specimens for culture
and their impact on the accuracy of urine culture microbiology.
Rating criteria were used for evaluating these practices. Specific
practices examined included collection methods for men, women,
children, and infants; preservation of urine samples in boric acid
solutions; and the effect of refrigeration on urine storage. The
evidence supporting these practices for minimizing contaminated
urine cultures and the impact on the accuracy of patient diagnosis
were evaluated by applying the LMBP initiative’s systematic re-
view methods for quality improvement practices and by translat-
ing the results into evidence-based guidance (24). The methodol-
ogy has recently been used to evaluate preanalytical practices for
reducing blood culture contamination (25) and blood sample he-
molysis (26).
A-6 CYCLE FOR SYSTEMATIC REVIEW
The CDC’s LMBP “A-6 Cycle” systematic review methods for
evaluating quality improvement practices was used for conduct-
ing this review. The methodology, reported in detail elsewhere
(24), is derived from previously validated methods. It is designed
to assess the results of studies of practice effectiveness that lead to
best-practice recommendations that are evidence based. Using
this method, a review coordinator (author Mark T. LaRocco) and
individuals trained to apply the LMBP methods (authors Alice S.
Weissfeld and Elizabeth K. Leibach) conducted the systematic re-
view with guidance from an expert panel. The expert panelists
(authors Nancy E. Cornish, Colleen S. Kraft, Vickie Baselski, Rob-
ert L. Sautter, Edward J. Peterson, and Debra Rodahl) were chosen
based on their breath of experience and perspective in clinical
microbiology and laboratory management. A description of their
scientific credentials and professional affiliations can be found in
the author biography section. Lastly, the team was supported by a
statistician with expertise in evidence review methodologies and
meta-analysis (author Jacob Franek). The expert panel reviewed
the results of the evidence review and drafted the evidence-based
best-practice recommendations. The recommendations were
then approved by the LMBP Workgroup, consisting of 13 invited
members with broad expertise in laboratory medicine, clinical
practice, health services research, and health policy, as well as one
ex officio representative from the Centers for Medicare and Med-
icaid Services. A list of the members of the LMBP Workgroup is
provided in Appendix 1.
Review Question, Analytical Framework, and Search
Strategy
The review question addressed by this analytical review was as
follows: “Are there preanalytic practices related to the collec-
tion, preservation, transport, and storage of urine for microbi-
ological culture that improve the diagnosis and management of
patients with urinary tract infection?” Components of the pre-
analytic phase of urine culture were studied in the context of an
analytical framework for factors affecting specimen contami-
nation and diagnostic accuracy, depicted in Fig. 1. The popu-
lation, intervention, comparison, and outcome (PICO) ele-
ments are as follows.
• “Population” is any patients who have urine cultures col-
lected.
• “Intervention” is clinical practice.
• “Comparison” is made of
X immediate versus delayed processing of urine held at
room temperature,
X immediate versus delayed processing of refrigerated
urine or urine preserved in boric acid,
X midstream clean-catch collection of urine without
cleansing versus with cleansing (men and women),
X midstream clean-catch collection of urine without
cleansing versus with cleansing versus collection with a
sterile urine bag versus diaper collection for infants and
children.
• “Outcomes” are the results of determining the contamina-
tion rate and the diagnostic accuracy of urine culture.
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Specific practices involving the preanalytic phase of urine cul-
ture covered in this evidence-based review were addressed by ask-
ing the following eight clinical questions.
1. What is the difference in colony counts when comparing
immediate versus delayed processing of fresh urine stored
at room temperature after collection?
2. What is the difference in colony counts when comparing
immediate versus delayed processing of urine kept refriger-
ated or preserved in boric acid?
3. What is the difference in contamination rates between mid-
stream urine collected with cleansing versus without cleans-
ing in women being tested for a UTI?
4. What is the diagnostic accuracy of midstream urine col-
lected with or without cleansing compared to bladder cath-
eterization for the diagnosis of UTI in women?
5. What is the difference in contamination rates between mid-
stream urine collection, with or without cleansing, and
first-void collection in men?
6. What is the diagnostic accuracy of midstream urine col-
lected, with or without cleansing, compared to that of blad-
der catheterization or suprapubic aspiration for the diagno-
sis of UTI in men?
7. What are the differences in contamination rates between
midstream collection with cleansing, midstream collection
without cleansing, and sterile urine bag or diaper collection
in children?
8. What is the diagnostic accuracy of midstream clean-catch,
sterile urine bag, or diaper collection compared with that of
suprapubic aspiration or catheterization for the diagnosis of
UTI in children?
The search for studies of practice effectiveness was conducted to
identify those with measurable outcomes collected to the rigor of
review requirements. With input from the expert panel and assis-
tance of a research librarian at the Jesse Jones Library at the Texas
Medical Center in Houston, TX, a literature search strategy and
set of terms were developed. A search of three electronic biblio-
graphic databases (PubMed, SCOPUS, and CINAHL) for English-
language articles published between 1965 and 2014 was con-
ducted. In addition, hand searching of bibliographies from
relevant information sources was performed. All search results
were catalogued and maintained using a Web-based, commer-
cial reference software package (RefWorks; ProQuest LLC,
Ann Arbor, MI). Finally, solicitation of unpublished quality
improvement studies was attempted by posting requests for data
on both the Laboratory Medicine Best Practices website (https:
//wwwn.cdc.gov/futurelabmedicine/) and two listservs supported
by the American Society for Microbiology: clinmicronet
(http://www.asm.org/index.php/online-community-groups/listservs)
and DivCNet (http://www.asm.org/division/c/divcnet.htm).
The search contained the following medical subject headings
(MESH) and key text words: “urinary tract infections” (MESH)
OR UTI (text word) OR urinary tract infect* (text word); “urine/
analysis” (major) OR “urine/microbiology” (major) OR “urinal-
ysis” (MESH); “specimen handling” (major); “preservation, bio-
logical” (MESH) OR preservation, biological (text word) OR
“boric acids” (MESH) OR boric acid (text word) OR boric acid/
borate (text word) OR boric acids (text word) OR “refrigeration”
(MESH) OR refrigeration (text word) OR preserv* (text word);
storage (text word); “time factors” (MESH) OR “transportation”
(MESH) OR transport time (text word) OR delay (text word) OR
time delay (text word) OR time factor (text word) OR timing (text
word); “urine specimen collection” (MESH) OR urine specimen
collection (text word) OR “catheters, indwelling” (MESH) OR
catheters, indwelling (text word) OR “urinary reservoirs, conti-
nent” (MESH) OR urinary reservoirs, continent (text word) OR
“urinary catheterization” (MESH) OR urinary catheterization
(text word) OR “intermittent urethral catheterization” (MESH)
FIG 1 LMBP QI review question and analytic framework. Are there preanalytic practices related to the collection, storage, preservation, and transport of urine
for microbiological culture that improve the diagnosis and management of patients with urinary tract infection? CAP, College of American Pathologists; ID’s,
identifications; ASTs, antimicrobial sensitivity tests; LOS, length of stay.
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OR intermittent urethral catheterization (text word) OR clean
voided (text word) OR midstream (text word) OR midstream
(text word) OR midstream (text word) OR foley (text word) OR
suprapubic (text word); and “bacteriological techniques”
(MESH) OR bacteriological technique (text word) OR bacterio-
logical techniques (text word) OR “microbiological techniques”
(MESH) OR microbiological technique (text word) OR microbi-
ological techniques (text word).
Titles and abstracts were initially screened by the review coor-
dinator, with assistance from the expert panel when necessary, to
select studies for a full review. A study was included if it was con-
sidered likely to provide valid and useful information and met the
PICO criteria previously discussed. Specifically, these inclusion
criteria required that a study (i) address a defined population/
definable group of patients, (ii) evaluate a specific intervention/
practice included in this review, (iii) describe at least one finding
for a relevant outcome measure (percent contamination, diagnos-
tic accuracy) reproducible in comparable settings, and (iv) present
results in a format which was useful for statistical analysis. Studies
failing to meet the inclusion criteria (not considered to report a
relevant practice, did not include a practice of interest, or did not
present an outcome measure of interest) were excluded from fur-
ther review.
Studies that cleared this initial screening were then abstracted
and evaluated by the expert panel. For eligible studies, informa-
tion on study characteristics, interventions, outcome measures,
and findings of the study was extracted using a standardized form
and assigned a quality rating derived from points awarded for
meeting quality criteria. Individual quality ratings were based on
four dimensions: study quality, practice effectiveness, defined
outcome measure(s), and findings/results. The objective for rat-
ing individual study quality was to judge whether sufficient evi-
dence of practice effectiveness was available to support inclusion
in an overall body of evidence for evaluation of a best-practice
recommendation (that is, a practice likely to be effective in im-
proving one or more outcomes of interest in comparison to other
commonly used practices).
The four study quality dimensions were rated separately, with a
rating score assigned up to the maximum for a given dimension.
The rating scores for all four dimensions were added to reach a
single summary score reflecting overall study quality. A total of 10
points were available for each study. Reviewers assigned one of
three quality ratings to each study: good (8 to 10 points), fair (5 to
7 points), or poor (4 points or less). Each study was reviewed and
rated by two expert panel members to minimize subjectivity and
bias. Any study ranked as poor by one reviewer but good by the
second reviewer was assigned to a third expert panel member for
resolution. More detail on the rating process of individual studies
can be found elsewhere (24–26). Studies that did not meet a study
quality rating of fair or good were excluded from further consid-
eration. Data from published studies that passed a full review were
transformed to a standardized, common metric according to
LMBP methods (24). Summary data and quality scores for each
publication included in this evidence-based review can be found
in Appendix 3 below.
The study quality ratings and results from the individual
studies for each clinical question were aggregated into bodies of
evidence. The consistency of effects and patterns of effects
across studies and the rating of overall strength of the body of
evidence (high, moderate, low, suggestive, and insufficient)
were based on both qualitative and quantitative analyses. Esti-
mates of effect and the strength of the body of evidence were
then used to translate results into one of three evidence-based
recommendations (recommend, no recommendation for or
against, recommend against). The ratings criteria are described
in greater detail elsewhere (24).
While recommendations are based on the entire body of ev-
idence, meta-analyses to generate summary estimates of effect
were undertaken for outcomes that provided sufficient data for
measurements of diagnostic accuracy and contamination, i.e.,
proportions of specimens containing periurethral, perianal,
epidermal, or vaginal flora. For the outcome of contamination
proportion, summary odds ratios were calculated using Man-
tel-Haenszel methods in a random-effects model performed
using Review Manager (RevMan) software version 5.0 (2008;
The Nordic Cochrane Centre, The Cochrane Collaboration,
Copenhagen, DK). A contamination event was defined accord-
ing to how individual studies defined contamination because
definitions varied between studies. Wherever possible, con-
tamination proportions were determined for the entire test
population rather than a subset population (such as only
among those individuals that tested negative for urinary tract
infection). The I2 statistic, which describes the percentage of
variability in effects estimates due to statistical heterogeneity
rather than sampling error, was used to assess between-study
heterogeneity. For the outcomes of diagnostic accuracy, it was
planned that point estimates of sensitivity and specificity
would be summarized using the bivariate model when similar
cutoff points were used; however, all models failed to converge
due to a too-small number of study or sample sizes. Similarly,
hierarchical summary receiver operator characteristic curves
(HSROC) could not be generated because these models too
failed to converge. Solutions for failure of convergence, includ-
ing removing individual studies, were explored but did not
improve convergence. Meta-analysis of diagnostic accuracy
outcomes and curve fitting were not pursued further given the
limitations of univariate methods. All work on summarizing
diagnostic accuracy outcomes was performed using SAS soft-
ware version 9.2 (2008; SAS Institute Inc., Cary, NC, USA) and
the MetaDAS macro, version 1.3 (27). Significant growth (i.e.,
a positive sample) was defined according to how each individ-
ual study defined significant growth because cutoff points
tended to vary among studies. All other growth, including con-
tamination and no growth, were considered nonsignificant
growth (i.e., a negative sample), as this most closely reflects
actual clinical practice. Two-by-two tables were used to deter-
mine sensitivity and specificity, and exact 95% confidence in-
tervals were calculated.
Search Results
Search results produced 5,092 unique documents that were
initially screened for eligibility to contribute to evidence of
effectiveness for practices defined by the eight clinical ques-
tions posed (storage and preservation of urine, collection of
urine from women, collection of urine from men, and collec-
tion of urine from infants and children). There was no response
to requests for unpublished data. The reduction of studies
through the screening process is detailed in Fig. 2. Initial
screening for topic relevance eliminated 4,917 studies. From
the remaining 171 studies, 124 were eliminated for not meeting
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the inclusion criteria (i.e., having elements potentially relevant
to at least one topic area review question, reporting practices
that are in use and available for adoption, reporting practices
reproducible in other comparable settings, and addressing a
defined population/definable group of patients). Forty-seven
studies met the criteria for inclusion and were subjected to full
abstraction and quality scoring. After an additional 12 studies
were excluded because of insufficient quality scores, the re-
maining 35 were included in the statistical analysis: 10 studies
on storage and preservation, 8 studies on collection from
women, 3 studies on collection from men, and 14 studies on
collection from infants and children.
STORAGE AND PRESERVATION OF URINE
Summary information on the 10 published studies comprising
the body of evidence for the clinical questions on the storage
and preservation of urine is presented in Tables 1 and 2. The
publication dates for these studies range from 1969 (28) to
1999 (29). All studies were given a “fair” quality rating. Three
studies examined the effect of prolonged storage of clean-catch
FIG 2 Systematic review flow diagram.
TABLE 1 Body-of-evidence table for clinical question 1, namely, “what is the difference in colony counts when comparing immediate and delayed
(4 h) processing of fresh urine stored at room temperature after collection?”a
Study (reference),





100 random samples of urine were cultured
within 2 h of collection and then again after




Not given SG was defined as any growth of 105 CFU/ml.
All other growth was considered NSG. Upon
receipt, there were 47 SG and 53 NSG




175 clean-catch urine samples were divided,
and one portion was treated with boric acid
at a concn of 20 g/liter and the other held
in a sterile tube. All samples were cultured
upon receipt in the laboratory and again





6 mo SG was defined as 105 CFU/ml of 1 or 2
species. All other growth was considered
NSG. Upon receipt, there were 38 SG and
137 NSG specimens. At 4 h, there were 42 SG
and 133 NSG specimens. At 24 h, there were
90 SG and 82 NSG specimens. At 48 h, there
were 109 SG and 66 NSG specimens.
Porter and Brodie
(28), fair
130 midstream urine specimens that had been
collected in sterile tubes and kept at room
temp or preserved with 0.5 g of boric acid
were mailed to a laboratory and cultured
immediately upon receipt (avg delay of 24




Not given SG was defined as any growth of 105 CFU/ml.
All other growth was considered NSG. Upon
receipt, there were 40 SG and 90 NSG
specimens. After 72 h, there were 93 SG and
37 NSG specimens.
a SG, significant growth; NSG, nonsignificant growth.
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TABLE 2 Body-of-evidence table for clinical question 2, namely, “what is the difference in colony counts when comparing immediate and delayed
(24 h) processing of urine kept refrigerated or preserved in boric acid?”a
Study (reference),





792 midstream specimens of urine from 792 general practice
patients were received preserved in 18 g/liter BA. Samples
were cultured within 8 h of laboratory receipt





Not given SG was defined as 105 CFU/ml of a single species.
All other growth was considered NSG. Positive
agreement (sensitivity) was 76.1% between
immediate and delayed specimens. Negative




Midstream clean-catch or catheterized urine was collected
from patients suspected of having UTIs. Split samples
were transported to the laboratory in either refrigerated
sterile tubes or in Becton, Dickinson urine culture kit
tubes containing GBF. Sterile urine was cultured
immediately upon arrival (immediate), and preserved
specimens were cultured again after storage for 24 and 48
h at room temp (delayed).
Clinical Microbiology Laboratory,
Mayo Clinic, Rochester, MN
Not given SG was defined as any growth of 105 CFU/ml. All
other growth was considered NSG. For phase 1 of
the trial, positive agreement (sensitivity) between
immediate and delayed cultures was 87.3%.
Negative agreement (specificity) was not reported.
Hubbard et al.
(34), fair
A total of 100 random clinical urine specimens were divided
and tested to compare urine preserved in Becton,
Dickinson urine culture kit tubes containing GBF with






Not given SG was defined as 105 CFU/ml of a single
pathogenic species. All other growth was
considered NSG. Phase 1 study data were used.
With immediate culture in GBF, there were 25
specimens showing SG and 75 showing NSG. After
a delay of 24 h, there were 22 specimens showing
SG and 78 showing NSG. With refrigeration and
immediate culture of fresh urine, there were 26
specimens showing SG and 74 specimens showing
NSG. After a delay of 24 h with refrigeration,
results had not changed.
Lauer et al. (35),
fair
1,000 urine specimens from children and adults suspected of
having UTIs were received by the laboratory. Upon
receipt, specimens were refrigerated until they could be
cultured. Specimens were then cultured immediately
(immediate) or split into 2 samples: 1 refrigerated for
18–24 h (delayed) and 1 preserved with Becton,
Dickinson urine culture kit tubes of GBF for 18–24 h




Not given SG was defined as 105 CFU/ml of a single
pathogenic species. All other growth was
considered NSG. Positive agreement between the
results of immediate and delayed culture in GBF
was 93.2%; negative agreement was 99.9%.
Positive agreement between immediate and
delayed culture while samples were refrigerated
was 93.2%; negative agreement was 100.0%.
Lum and Meers
(31), fair
175 clean-catch urine samples obtained from various
hospital wards and clinics were divided; 1 portion was
treated with BA at a concn of 20 g/liter and the other held
in a sterile tube. All samples were cultured upon receipt
in the laboratory (immediate) and again after 4 h, 24 h,
and 48 h of storage at room temp (delayed).
Microbiology Department,
University of Singapore, Kent
Ridge, Singapore
6 mo SG was defined as 105 CFU/ml of 1 or 2 species. All
other growth was defined as NSG. With
immediate culture, there were 29 specimens
showing SG and 146 showing NSG. After 24 h,




130 midstream urine specimens were collected in sterile
tubes kept at room temp or preserved with 0.5 g of boric
acid, mailed to the laboratory, and cultured immediately
upon receipt, with an avg delay of 24 h before receipt
(immediate). They were cultured again after 72 h of
storage at room temp (delay).
Laboratory, City Hospital,
Aberdeen, Scotland
Not given SG was defined as any growth of 105 CFU/ml. All
other growth was defined as NSG. With
immediate culture in BA, there were 18 specimens
showing SG and 112 showing NSG. After a delay





312 midstream urine specimens were transported to the
laboratory in either sterile tubes or Becton, Dickinson
urine culture kit tubes containing GBF. All specimens
were tested immediately upon receipt. If not tested within
20 min, specimens were refrigerated. Preserved specimens
were retested after being held for 24 h at room temp.
Parkland Memorial Hospital,
Dallas, TX
Not given SG was defined as 5  104 CFU/ml of any growth.
All other growth was defined as NSG. With
immediate culture of specimens preserved in GBF,
there were 8 specimens showing SG and 180
showing NSG. After a delay of 24 h, there were 40
specimens showing SG and 148 showing NSG.
Weinstein (37),
fair
869 urine specimens obtained from inpatients in 3 medical
units were split and transported to the laboratory in
either sterile tubes, Becton, Dickinson urine culture kit
tubes containing GBF, or Becton, Dickinson Vacutainer
tubes containing SBF. All specimens were cultured
immediately upon receipt (immediate) and then again
after being held for 24 h at either room temp (BA tubes)
or under refrigeration (sterile tubes).
Middlesex General University
Hospital, New Brunswick, NJ
6 mo SG was defined as 105 CFU/ml of a single species.
All other growth was defined as NSG. Only results
of GBF preservation are reported here since only
the latter half of patients had samples also stored
in SBF. With immediate culture in GBF, there
were 106 specimens showing SG and 763 showing
NSG. After 24 h, there were 97 specimens showing
SG and 765 showing NSG (7 fewer patient
specimens were available for analysis). For
refrigeration, with immediate culture of fresh
urine, there were 111 specimens showing SG and
758 showing NSG. After a delay of 24 h, there were
104 specimens showing SG and 758 showing NSG
(7 fewer patient specimens were available for
analysis).
Wright et al. (32),
fair
Fresh urine specimens received by the laboratory were
preserved in 3 formulations of BA: 5.5% pure BA, BA in
Becton, Dickinson urine culture kit tubes containing
GBF, and BA in Becton, Dickinson Vacutainer tubes
containing SBF. They were tested for the presence of
bacteria by culture and by various screening methods for
assessing bacteriuria. Samples of fresh urine were tested
upon receipt by the laboratory (immediate), and
preserved samples were tested after being held for 24 h at
room temp (delay).
Department of Pathology,
University of Utah Medical
Center, Salt Lake City, UT
Not given SG was defined as any growth of 105 CFU/ml.
Results of a BacT screen (culture results were not
reported) were used to assess positivity. For
samples preserved in BA, there were 48 showing
SG with immediate culture and 41 showing SG
after a delay of 24 h. For GBF samples, there were
49 showing SG with immediate culture and 46
showing SG with delayed culture. For SBF
samples, there were 96 showing SG with
immediate culture and 92 showing SG with
delayed culture. Results of the 3 BA groups were
combined for analysis.
a BA, boric acid; GBF, glycerol-boric acid-sodium formate; SBF, sorbitol-boric acid-sodium formate; SG, significant growth; NSG, nonsignificant growth.
Urine Culture Preanalytics
January 2016 Volume 29 Number 1 cmr.asm.org 111Clinical Microbiology Reviews
urine at room temperature by culturing samples of urine im-
mediately upon receipt and then again after 2 h and 4 h (30),
after 4 h, 24 h, and 48 h (31), or after 24 h and 72 h (28) of
storage at room temperature. Nine studies tested the effect of
preserving urine in boric acid for 24 h on colony counts and
compared the results with the results of immediate culture.
Several different boric acid formulations were used, including
boric acid alone (29, 31, 32), glycerol-boric acid-sodium for-
mate (32–37), and sorbitol-boric acid-sodium formate (32,
37). The length of delay of culture while samples were pre-
served in boric acid was assessed at various time points across
studies, but 24 h was chosen for analysis as it was the most
common endpoint. Three studies examined the effect of 24-h
refrigeration of urine samples on changes in colony counts
from those of immediate culture (33, 35, 37). The majority of
studies used clean-catch midstream urine samples, although
collection methods were undefined in five studies (30, 32, 34,
35, 37). Growth was defined as either “significant” or “nonsig-
nificant.” The definitions of significant growth varied among
studies, but in general, a threshold of 105 CFU/ml of one or
two species of bacteria was used.
Body-of-Evidence Qualitative Analysis
The difference in colony counts when immediate and delayed pro-
cessing of urine specimens stored at room temperature were com-
pared is shown in Table 3. Data from three observational studies
(28, 30, 31) found a moderate increase (approximately 10%) in
colony counts after 4 h of storage at room temperature and a large
increase (135%) in colony counts after storage for 24 h or more.
The effect of delayed culture on urine specimens kept refrigerated
or preserved in solutions of boric acid is shown in Tables 4, 5, and
6. Data from three observational studies (29, 33, 35) found 73 to
93% positive agreement (sensitivity) and 96 to 100% negative
agreement (specificity) between the results of immediate culture
and after a 24-h delay with specimens preserved in boric acid. Data
from one study (35) found 93% positive agreement and 100%
negative agreement between specimens cultured immediately
upon receipt versus after a 24-h delay with refrigeration (Table 4).
Colony counts in urine samples either refrigerated or chemically
preserved showed similar results. Five studies (31, 32, 34, 37, 38)
showed that urine samples preserved in boric acid solutions for 24
h (Table 5) or refrigerated for 24 h (Table 6) had only minor
changes in the numbers of cultures with either significant or non-
significant growth.
These data suggest that both boric acid and refrigeration
adequately preserve urine specimens prior to their processing
for up to 24 h. Furthermore, the results suggest that urine held
at room temperature for more than 4 h should not be processed
due to overgrowth of both clinically significant and contami-
nating microorganisms. Based on statistical analysis of the
data, however, the overall strength of this body of evidence was
rated as low.
COLLECTION OF URINE FROM WOMEN
Summary information on the eight published studies comprising
the body of evidence for the clinical questions on contamination
rates and the diagnostic accuracy of midstream urine collection
from adult females is presented in Tables 7 and 8. Three studies
(39–41) were given a quality rating of “good,” and five studies (38,
42–45) were rated as “fair.” Five studies (38–40, 42, 43) examined
the impact of perineal cleansing on contamination and are sum-
marized in Table 7. Patient settings included a clinic for adoles-
cents (38), a general practice (38), an antenatal ambulatory-care
clinic (39, 43), and a health center for teenagers (40). Definitions
of contamination varied among studies and included any
growth of normal vaginal flora and/or small quantities (2,000
CFU/ml) of pathogenic bacteria (38), the presence of epithelial
cells (42), mixed growth in quantities of 105 CFU/ml (39) or at
any quantity (43), and growth of any nonpathogen or pathogen in
quantities of 104 CFU/ml (43) or 105 CFU/ml (40).
Three studies (41, 44, 45) examined the diagnostic accuracy of
midstream urine collection with or without cleansing, with
straight urinary catheterization as the reference standard (Table
8). Patient populations in these studies included women present-
ing to an emergency department (41) or ambulatory clinic (44) or
admitted to a general medical ward (45). In two studies (43, 44),
each patient had urine collected by midstream collection with
cleansing, followed by a second collection by urinary catheteriza-
tion. In the third study (46), no cleansing was performed prior to
midstream collection.
Body-of-Evidence Qualitative Analysis
The evidence examining the impact of perineal cleansing on con-
tamination of midstream urine specimens collected from females
is depicted in Fig. 3. Data from four observational studies (38, 40,
42, 43) and one randomized control trial (39) found no difference
TABLE 3 Difference in colony counts when results of immediate and




at 0 h (CFU/ml)
Increase in significant
growth (%) at:
4 h 24 h 48 h 72 h
Lum and Meers (31) 38 11 137 187 ND
Hindman et al. (30) 47 9 ND ND ND
Porter and Brodie (28) 40 ND ND ND 233
a The quality rating of each study was fair. ND, not determined.












Lauer et al. (35) GBF Refrigeration 18–24 h in GBF 105 93 (86–97) 100 (99–100)
Gillespie et al. (29) BA 8 h in BA Overnight in BA 105 76 (68–82) 96 (94–97)
Guenther and Washington (33) GBF Refrigeration 24 h in GBF 105 87 (78–93) ND
Lauer et al. (35) Refrigeration 18–24 h of refrigeration 105 93 (86–97) 100 (100–100)
a The quality rating of each study was fair. GBF, glycerol-boric acid-sodium formate; BA, boric acid; 95% CI, 95% confidence interval; ND, not determined.
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in the odds of contamination between midstream urine specimens
collected with or without cleansing. The overall strength of this
evidence was rated as high. The diagnostic accuracy of midstream
urine collection with or without cleansing is shown in Table 9.
Using catheterization as the reference standard, midstream collec-
tion had a sensitivity of 98 to 100% and a specificity of 95 to 100%.
However, the overall strength of this body of evidence was rated
as low.
COLLECTION OF URINE FROM MEN
Summary information on the three published studies comprising
the body of evidence for the clinical questions on contamination
and diagnostic accuracy of midstream urine collection from adult
males is presented in Tables 10 and 11. One study (46) was given a
quality rating of “good,” and two studies (47, 48) were rated as
“fair.” Two studies (46, 47) examined contamination in mid-
stream clean-catch specimens compared to that in first-void col-
lection specimens (Table 10). Patients in both studies were either
ambulatory or hospitalized men with symptoms of urinary tract
infection being seen at a VA Medical Center. In the first study (46),
men had a first-void and/or midstream urine sample collected,
but only half of the patients were asked to wash their glans penis
prior to collection. In the second study (47), urine specimens from
men were obtained by midstream clean-catch collection, first-
void collection, straight catheterization, and suprapubic bladder
aspiration, with 7 men being sampled more than once. Contami-
nation was defined as either the growth of 103 CFU/ml of two or
more colony types (46) or any growth of three or more microbial
species (47). For the meta-analysis, only those samples obtained
via midstream clean-catch collection and first-void collection
without cleansing were compared.
Two studies (47, 48) examined the diagnostic accuracy of mid-
stream urine collection from men using either straight catheter-
ization or suprapubic aspiration as the reference standard (Table
11). One study (47) compared midstream clean-catch specimens
to those collected by suprapubic aspiration or straight catheteriza-
tion in a group of hospitalized or ambulatory men, while the sec-
ond study (48) compared midstream clean-catch specimens to
specimens collected by suprapubic aspiration in a group of pa-
tients with spinal cord injury without indwelling catheters. Signif-
icant growth in one study (47) was defined as 104 CFU/ml of a
single or predominant species for midstream clean-catch speci-
mens or 103 CFU/ml for specimens collected by straight cathe-
terization or suprapubic aspiration. Significant growth in the sec-
ond study (48) was defined as any growth of 104 CFU/ml for
either collection method.
Body-of-Evidence Qualitative Analysis
The evidence comparing levels of contamination after mid-
stream urine collection and uncleansed first-void collection is
shown in Fig. 4A. Summary data from both studies (46, 47)
found a large (77%) reduction in the odds of contamination in
favor of midstream clean-catch over first-void specimens. The
strength of this evidence was rated as high. Only one study (46)
compared midstream collection with cleansing to midstream
collection without cleansing (Fig. 4B). Results showed no dif-
ference in contamination between the two methods of collec-
tion. However, imprecision was largely due to the small event
size. The diagnostic accuracy of midstream urine collection
from men, with straight catheterization or suprapubic aspira-
tion used as the reference standard, is shown in Table 12. Data
for both studies found high diagnostic sensitivity (82 to 100%)




NSG present SG present








Weinstein (37) 105 758 0.9b 111 6.3b
Hubbard et al. (34) 105 74 0 26 0
a Both studies were given a quality rating of fair. NSG, nonsignificant growth; SG, significant growth. Both studies immediately cultured fresh specimens and specimens that had
been kept under refrigeration for 24 h.
b There were 7 fewer patient samples available for analysis with delayed culture (862 patient pairs versus 869); percentages of increase were calculated assuming 869 pairs.

























Southern and Luttrell (36) GBF GBF 24 (GBF) 5  104 180 17.8 8 500.0
Lum and Meers (31) BA GBF 24 (GBF) 105 146 2.1 29 10.3
Wright et al. (32) BA, GBF, SBF None (fresh specimens
were used)
24 (BA, GBF, SBF) 105 193 7.3
Weinstein (37) GBF, SBF GBF 24 (GBF) 105 763 1.2b 106 8.5b
Hubbard et al. (34) GBF GBF 24 (GBF) 105 75 4.0 25 12.0
Porter and Brodie (28) BA BA 72 (BA) 105 112 0 18 0
a GBF, glycerol-boric acid-formate; BA, boric acid; SBF, sorbitol-boric acid-formate; NSG, nonsignificant growth; SG, significant growth. All studies were given a quality rating of
fair.
b There were 7 fewer patient samples available for analysis with delayed culture (862 patient pairs versus 869); the percent increase was calculated assuming 869 pairs.
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TABLE 7 Body-of-evidence table for clinical question 3, namely, “what is the difference in percentages of contamination between midstream urine
collection with cleansing versus without cleansing in women being tested for a UTI?”a
Study (reference),





50 asymptomatic females aged 14–23 yr
nonrandomly assigned to the MSCC




2 mo Contamination was defined as growth of
bacteria found in normal vaginal or
skin flora that does not cause UTI. 8
samples showed no growth in the
MSCC group, and 5 showed no
growth in the MS group. 1 sample in
the MS group grew pathogenic
bacteria (2,000 CFU/ml). The
remaining 36 samples were
contaminated. Of the remaining 36,
33 grew mixed Gram-positive
colonies, 2 grew mixed Gram-positive
and -negative colonies, and 1 grew
staphylococcal species.
Bradbury (42), fair 158 female patients suspected of having UTIs
and 158 controls, all aged 16–75 yr. 316
urine specimens were collected via MSCC
or MS. The control group comprised the
next nonpregnant female attending with
no urinary tract symptoms. Urine was
collected into a sterile boric acid
container. Specimens were transported to
the laboratory after morning surgery.
Those collected in the evening were stored




Not given Contamination was defined by the
presence of epithelial cells. There were
11 contaminated specimens among
the 176 in the MSCC group and 17
contaminated specimens among the
138 in the MS group.
Holliday et al.
(39), good
192 asymptomatic antenatal ambulatory
women randomly allocated into the
MSCC or MS group for urine specimens.
No preservatives were used, and samples
were processed within 2 h of collection.




Not given Contamination was defined as mixed
growth of 105 CFU. There were 14
contaminated samples from the 96
women in the MSCC group and 12
contaminated specimens from the 96
women in the MS group.
Schlager et al.
(40), good
100 pregnant asymptomatic adolescents aged
10–19 yr in all stages of pregnancy who
enrolled during a routine prenatal visit.
Each patient provided 2 urine samples
collected during consecutive urinations
(MSCC or MS). No preservatives were
used. Urinalysis and bacterial culture were





Not given Contamination was defined as 105
CFU/ml of a pathogen or any no. of
nonpathogens. There were 62
contaminated samples from the 100
women in the MSCC group and 55




113 pregnant women. 3 urine samples were
self-obtained from each woman by UFV,
MS, and MSCC. Oral and written
instructions were provided. Urine samples
were refrigerated and analyzed within 48 h
of collection
Obstetric clinic (Vida) in
Amsterdam, Netherlands
1 yr Contamination was defined as growth of
at least 2 or more organisms. 336
urine samples were analyzed (113
UFV, 112 MS, and 111 MSCC
specimens). There was 1
contaminated specimen out of 112
MS specimens and 3 contaminated
specimens out of 113 MSCC
specimens. If contamination was
defined as growth of 104 CFU of
skin flora/ml by culture, there were 47
contaminated specimens out of 112
MS and 42 contaminated specimens
out of 111 MSCC specimens.
a MSCC, midstream collection with perineal cleansing; MS, midstream collection; UFV, first-void urine collection (morning).
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and specificity (92 to 100%) for midstream clean-catch collec-
tion. However, the overall strength of this body of evidence was
rated as low.
COLLECTION OF URINE FROM CHILDREN
Summary information on the 14 published studies comprising
the body of evidence for the clinical questions on contamina-
tion rates and the diagnostic accuracy of midstream urine col-
lection from children is presented in Tables 13 and 14. Four
studies (49–52) were given a quality rating of “good,” and 10
studies (53–62) were rated as “fair.” Six studies (49, 50, 53–56)
compared differences in contamination rates in urine collected
by midstream collection (with or without cleansing), collected
with a sterile urine bag, or collected from diapers (Table 13).
Patients studied ranged in age from 1 month to 18 years. Def-
initions of contamination varied among studies and included
mixed growth in any concentration (54), mixed growth in any
concentration or any growth of 105 CFU/ml (49–51), and
mixed growth at a concentration of 105 CFU/ml (56); any
specimen interpreted as contaminated by the clinical microbi-
ology laboratory was also included (53).
Eight studies (51, 52, 57–62) examined the accuracy of mid-
stream clean-catch, sterile urine bag, or diaper collection, with
suprapubic aspiration or straight catheterization used as the ref-
erence standard for diagnosing urinary tract infections in children
(Table 14). Patient age ranged from 0 to 10 years. Definitions of
significant growth varied across studies, particularly for the refer-
ence standards. All studies except one defined significant growth
for midstream clean-catch, sterile urine bag, or diaper collection
as 105 CFU/ml. The remaining study (52) defined significant
growth by sterile urine bag collection as “pure growth.” Signifi-
cant growth for suprapubic aspiration or straight catheterization
TABLE 8 Body-of-evidence table for clinical question 4, namely, “what is the accuracy of midstream urine collection, with or without cleansing,
compared to catheterization for the diagnosis of UTI in women?”a
Study (reference),
quality rating Population and samplesa Setting
Time
period Results
Walter and Knopp (41),
good
105 women suspected of having a UTIs
and presenting to the emergency
department triage nurse. An MSCC
specimen and then a CATH
specimen were collected.
Department of Emergency Medicine,
Valley Medical Center, Fresno, CA
7 mo SG was defined as 104 CFU/ml of
a single species by either CATH
or MSCC. All other growth was
considered NSG. MSCC had a




The study was separated into 3 groups.
In group 1, 53 healthy student
nurses volunteered for MSCC with
no CATH. Group 2 consisted of 29
women, asymptomatic for UTI,
admitted to a general medical ward.
Both MSCC and CATH specimens
were collected. Group 3 consisted of
27 patients suspected of having a
UTI who were admitted to a
semiprivate or general medical ward.
Both MSCC and CATH specimens
were collected.
Hotel-Dieu Hospital, Montreal,
Canada, and Department of
Medicine, University of Montreal
School of Medicine, Montreal,
Canada
Not given SG was defined as 104 CFU/ml of
a single pathogenic species by
either CATH or MSCC. All
other growth was considered
NSG. Combining groups 2 and 3
yielded a sensitivity of 100% and
a specificity of 100%.
Immergut et al. (44),
fair
95 ambulatory females. Urine was
obtained via MS or CATH.
Specimens were immediately
cultured on Uricult medium by
dipping the slides into plastic cups.
Private practice, Bethesda, MD Not given SG was defined as any growth of
5  104 CFU/ml by either
CATH or MS. All other growth
was considered NSG. MS had a
sensitivity of 100% and a
specificity of 95%.
a MSCC, midstream collection with perineal cleansing; MS, midstream collection; CATH, catheterization.
FIG 3 Difference in contamination levels between midstream urine collected with cleansing (MSCC) versus without cleansing (MS) in women being tested for
urinary tract infection. M-H, Mantel-Haenszel statistic; 95% CI, 95% confidence interval.
Urine Culture Preanalytics
January 2016 Volume 29 Number 1 cmr.asm.org 115Clinical Microbiology Reviews
was defined as any growth in one study (51), growth of 102 CFU
in one study (59), growth of 103 CFU/ml in one study (62),
growth of 105 CFU/ml in three studies (57, 60, 61), and “pure
growth” in one study (52). In one study (58), the definition of
significant growth was unclear.
Body-of-Evidence Qualitative Analysis
The evidence comparing contamination rates for midstream
urine collection with cleansing, midstream collection without
cleansing, sterile urine bag collection, and diaper collection is
shown in Fig. 5. Data obtained from five observational studies
(49, 53–56) and one cluster-randomized controlled trial (50)
found larger reductions (68 to 73%) in the odds of contamina-
tion for specimens obtained by midstream collection with
cleansing than for specimens obtained by the other methods of
collection. Data from three observational studies (49, 54, 55)
found no significant differences in the odds of contamination
between specimens collected with sterile urine bags and speci-
mens taken from diapers. This body of evidence was rated as
high.
The accuracy of results for midstream clean-catch urine speci-
mens, sterile urine bag specimens, or diaper specimens, with
straight catheterization or suprapubic aspiration used as the ref-
erence standard for the diagnosis of urinary tract infection in chil-
dren, is shown in Fig. 6. Data from eight observational studies
showed varied results. The inability to meta-analyze the point es-
timates of sensitivity and specificity due to small sample and study
sizes, together with heterogeneity in positivity thresholds, made
interpretation difficult. Similarly, HSROC curves could not be
generated, and thus it is unclear which method of noninvasive
urine collection is most accurate for the diagnosis of urinary tract
infection in children.
ADDITIONAL CONSIDERATIONS
This section addresses additional considerations for evaluating
preanalytical practices associated with urine cultures and the
impact of these practices on contamination and diagnostic ac-
curacy.
Clinical Applicability
The studies included in this review reported collection, storage,
and preservation of urine samples through commonly used
methods for both children and adults in both inpatient and
outpatient settings; results are therefore likely to apply to other
health care environments. Many of the methods for collection,
storage, and preservation are widely recommended (18, 63)
and are typically used in most hospitals, outpatient clinics, and
clinical microbiology laboratories today (21, 22). The focus of
this review, however, is largely on clean-catch midstream urine
collection because this method remains the most commonly
used in most patient populations and settings (18). This is
primarily due to its noninvasiveness; i.e., it has no risk of pro-
ducing iatrogenic infection, despite the paucity of data sup-
porting its use as a standard (63).
Controversy remains among clinical microbiologists and infec-
tious disease physicians about the most accurate means for diag-
TABLE 10 Body-of-evidence table for clinical question 5, namely, “what is the difference in contamination between midstream urine collection,
with or without cleansing, from first-void collection from men?”a
Study (reference),
quality rating Population and samples
Time
period Results
Lipsky et al. (46),
good
254 men attending a urology clinic. 308 specimens were obtained by
UFV and MS. Half of the men (those with even Social Security
numbers) cleansed their glans penis, creating 4 distinct groups of
specimens: UFV, CFV, MS, and MSCC. All specimens were
immediately refrigerated and delivered to a laboratory within 4 h
of collection.
7 mo Contamination was defined as 103 CFU/ml of 2 or
more colonial types with no predominant
organism. 10 (6.4%) of the 157 MSCC specimens
were contaminated. 23 (15.2%) of the 151 UFV
specimens were contaminated. 16 (10.6%) of the
151 MS specimens were contaminated.
Lipsky et al. (47),
fair
66 ambulatory or hospitalized men who had acute dysuria or other
irritative genitourinary symptoms, were known to have
bacteriuria, or were scheduled for urologic procedure. 76
specimens in total from the 66 men (7 patients were restudied
[5 twice and 2 four times]) obtained by SPA, UFV, MSCC, and
CATH. The specimens were delivered to the laboratory within 30
min of collection and immediately inoculated.
Not given Contamination was defined as specimens containing
more than 2 microbial species. None (0%) of the
75 specimens in the MSCC group were
contaminated. 5 (6.9%) specimens of the 72 in the
UFV group were contaminated.
a MS, unclean midstream urine collection; MSCC, midstream clean-catch collection; UFV, first-void urine collection without cleansing; CFV, first-void collection with cleansing;
SPA, suprapubic aspiration; CATH, urethral catheterization. The setting for these studies was the VA Medical Center, Seattle, WA.
















Walter and Knopp (41) Good ND MSCC 104 104 98 (88–100) 97 (89–99)
Lemieux and St.-Martin (45) Fair Combined MSCC 104 104 100 (87–100) 100 (89–100)
Asymptomatic MSCC 104 104 ND 100 (88–100)
Symptomatic MSCC 104 104 100 (44–100) 95 (88–98)
Immergut et al. (44) Fair ND MS 5  104 5  104 100 (44–100) 95 (88–98)
a MSCC, midstream clean-catch collection; MS, midstream urine collection; ND, not determined. The reference standard for all tests was catheterization.
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nosing urinary tract infections, including the best methods of
specimen collection for women, men, children, and infants (19,
63). A recent collaboration between the American Society for Mi-
crobiology (ASM) and the Infectious Disease Societies of America
(IDSA), designed to assist physicians in the appropriate use of
laboratory tests for infectious diseases, addressed methods of
specimen collection, as well as guidelines for testing patients for
urinary tract infections (64). A recommendation was made for
collection of urine in a manner to minimize contamination and
included midstream collection with cleansing and immediate re-
frigeration of samples upon collection, although the lack of sup-
porting data was cited (64).
In applying the findings of this review, a strength assessment
of the overall body of evidence should be weighted by the qual-
ity of findings from individual reports most closely resembling
populations and settings of particular interest. For instance, an
overall body-of-evidence quality rating may decrease because
of the aggregate number of included studies omitting study
parameters of little applicability to a particular clinical setting.
Researchers may take guidance, with a higher degree of confi-
dence than the overall quality rating might indicate, from in-
dividual included studies of high or moderate strength which
address specific clinical populations or settings directly com-
parable to their research interests. The conduct of evidence-
based practice would guide clinicians to assess both the quality
and the “goodness of fit” of studies relevant to their own par-
ticular questions before applying findings in support of their
decisions.
This review has directed attention to the need for reexamina-
tion of preanalytic factors affecting urine culture. A great number
FIG 4 Difference in contamination levels between midstream collection with cleansing (MSCC) and first-void urine collection without cleansing (UFV) (A) or
midstream collection without cleansing (MS) (B) for men.
TABLE 11 Body-of-evidence table for clinical question 6, namely, “what is the accuracy of midstream urine collection compared to straight
catheterization or suprapubic aspiration for the diagnosis of UTI in men?”a
Study (reference),
quality rating Population and samples Setting(s)
Time
period Results
Lipsky et al. (47), fair 66 ambulatory or hospitalized men who had
acute dysuria or other irritative
genitourinary symptoms, were known to
have bacteriuria, or were scheduled for a
urologic procedure. 76 specimens in total
were obtained from the 66 men (7
patients were restudied [5 twice and 2
four times]) obtained by SPA, UFV,
MSCC, and CATH. Specimens were
delivered to the laboratory within 30 min
of collection and immediately inoculated.
VA Medical Center,
Seattle, WA
Not given SG was defined as 104 CFU/ml of a
single or predominant species
(90% of the plate’s growth) for
MSCC and 103 for SPA/CATH.
All other growth was considered
NSG. MSCC had a sensitivity of
82.4% and a specificity of 100.0%.
Deresinski and Perkash
(48), fair
53 male spinal cord injury patients who
were free of indwelling catheters. 71
samples of urine were obtained, 1 by
MSCC and 1 by SPA. Note that many of
the MSCC specimens were collected on
first void. Urine specimens were
processed for culture immediately.
Spinal Cord Injury Service,
VA, and Stanford
University Medical
Centers, Palo Alto, CA
Not given SG was defined as any growth of 104
CFU/ml for MSCC and SPA. All
other growth was considered NSG.
MSCC had a sensitivity of 100%
and a specificity of 100%.
a MSCC, midstream clean-catch collection; UFV, first-void urine collection without cleansing; SPA, suprapubic aspiration; CATH, urethral catheterization; SG, significant growth;
NSG, nonsignificant growth.
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of the studies covered in the review predate the regionalization
and other significant restructuring of the delivery of microbiolog-
ical services in the United States, which portend increased varia-
tion in collection, storage, and preservation methods. More
studies are needed to support recommendations for specific pop-
ulations, e.g., nursing facility residents needing skilled care. Im-
portant also is the growing need for documentation of health out-
comes and cost-effectiveness of current practices through the
implementation of well-designed, system-wide quality improve-
ment studies. Of equal importance is the need to expand (and














Lipsky et al. (46) SPA/CATH 104 104 82 (67–92) 100 (92–100)
Deresinski and Perkash (48) SPA 104 104 100 (92–100) 100 (87–100)
a MSSC, midstream clean-catch collection; SPA, suprapubic aspiration; CATH, straight catheterization. The quality rating of both studies was fair, and the index text for both was
MSSC.
TABLE 13 Body-of-evidence table for clinical question 7, namely, “what is the difference in contamination between MSCC, MS, SUB, and diaper
collection from children?”a
Study (reference),





1,067 children aged 0–16 yr suspected of having
UTIs. Urine was collected by either SUB
(n  517), MSCC (n  532), CATH (n  7),
or SPA (n  11). Some SUB and MSCC
samples were collected by parents. Within 30
min of collection, all specimens were sent to
the laboratory for culture.
Dr. Sami Ulus Children’s
Hospital, Ankara,
Turkey
2 mo Contamination was defined as those
specimens interpreted as “contaminated”
by the laboratory. 76 (14.3%) of 532
MSCC samples were contaminated,
compared with 227 (43.9%) of 517 SUB
samples.
Alam et al. (49),
good
191 children 3 yr without known UTIs. Urine
specimens were obtained by 3 different
methods: MSCC, DIAPER, and SUB. 534
urine samples were obtained from the 191
children. Urine was cultured within 2 h of
arriving at the laboratory.




2 mo Contamination was defined as mixed growth
or any growth of 105 CFU/ml. All
specimens with SG of a single species of
105 CFU/ml were excluded. 23 (14.7%)
of 156 MSCC specimens were
contaminated. 45 (26.6%) of 169 SUB
specimens were contaminated. 49 (29.0%)




88 children of 2 yr with various febrile
illnesses had 56 reliable urine samples
collected by DIAPER. 34 children of the same
age and from the same ward had SUB
samples collected. 240 MSCC samples were








3 mo Contamination was defined as mixed growth
at any concn. 34 (60.7%) of 56 DIAPER
specimens were contaminated. 23 (67.6%)
of 34 SUB specimens were contaminated.
64 (26.7%) of 240 MSCC specimens were
contaminated.
Ahmad et al. (55),
fair
45 infants aged 1– 23 mo. Urine specimens







Not given Contamination was defined as mixed growth
or any growth of 105 CFU/ml. 17
(37.8%) of 45 SUB specimens were




350 toilet-trained children aged 2–18 yr cluster-
randomized by week to urine collection
groups. 350 urine specimens were obtained
by either MSCC or MS with cleansing of the





11 mo Contamination was defined as mixed growth
of 2 or more organisms or any growth of
105 CFU/ml. 14 (7.8%) of 179 MSCC
specimens were contaminated. 41 (23.9%)
of 171 MS specimens were contaminated.
Tosif et al. (56),
fair
599 children of 2 yr of age (retrospective
observational study of urine culture results).
Urine specimens were obtained by MSSC,
SPA, CATH, or SUB. Contamination rates





1 mo Contamination was defined as growth of 2
or more organisms with colony counts of
105 CFU/ml. 52 of 202 MSCC
specimens were contaminated, and 6 of 13
SUB specimens were contaminated.
a SUB, sterile urine bag collection; MSCC, midstream clean-catch collection; CATH, catheterization; SPA, suprapubic aspiration; DIAPER, diaper collection; SG, significant growth.
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TABLE 14 Body-of-evidence table for clinical question 8, namely, “what is the accuracy of midstream clean-catch, sterile urine bag or diaper
collection compared with suprapubic aspiration or catheterization for the diagnosis of UTI in children?”a
Study (reference),






Children aged 10 yr of age suspected of
having UTIs. 287 urine specimens were
obtained by SPA, and 175 were obtained
by MSCC. For only 51 children, MSCC
results were compared with SPA results.
All samples were refrigerated after
collection for a maximum of 12 h until






Not given SG was defined as any growth in SPA
specimens and any growth of 105
CFU/ml in MSCC specimens. All
other growth was considered NSG.
MSCC had a sensitivity of 100% and
a specificity of 100% if one assumes
that the 5 specimens of SG collected
by MSCC were the same 5 specimens
of SG collected by SPA.
Pylkkanen et al.
(58), fair
477 patients (164 infants and 313 children)
suspected of having UTIs Urine
specimens were obtained by SPA and
SUB from infants (n  164) or by
MSCC from children (n  313). Culture
was performed immediately after
collection.




Not given SG was defined as consistent growth on
both blood agar and Uricult
dipslides for SPA specimens and any
growth of 105 CFU/ml for MSCC
specimens. Combining symptomatic
and asymptomatic patients, MSCC




120 patients. Cleanly voided urine samples
were collected simultaneously with or
immediately after SPA. Samples were
collected by SUB from infants of 18
mo (n  86) and by MSCC from
children 3–12 yr of age (n  34).
Immediately after collection, samples






Not given SG was defined as any growth of 102
CFU/ml for SPA specimens and any
growth of 105 for MSCC
specimens. All other growth was
considered NSG. MSCC had a
sensitivity of 71.4% and a specificity
of 80.0%. SUB had a sensitivity of
83.3% and a specificity of 56.5%.
Hardy et al. (60),
fair
30 patients aged 0 to 3 yr of age. Urine was
obtained by SUB, MSCC, and SPA. The
3 specimens were collected within 1 to 6
h of each other and not always in the
same order. Specimens were collected in
sterile plastic bottles and transported
immediately for culture or refrigerated








Not given SG was defined as 105 CFU/ml of a
single species for MSCC, SUB, and
SPA specimens. MSCC had a
sensitivity of 25.0% and a specificity
of 96.2%. SUB had a sensitivity of
50.0% and a specificity of 92.3%.
Ramage et al. (51),
good
49 infants of 24 mo of age suspected of
having UTIs. 58 paired urine cultures
were obtained by MSCC and SPA.
Royal Hospital for Sick
Children, Glasgow,
Scotland
Not given SG was defined as any growth in SPA
specimens and 105 CFU/ml of a
single species in MSCC specimens.
MSCC had a sensitivity of 88.9% and
a specificity of 95.0%.
Cohen et al. (61),
fair
38 infants of 2 yr of age who presented
with fever with no obvious cause. Urine
was collected either by SPA/CATH or by







Not given SG was defined as all growth of 105
CFU/ml of a single species in
DIAPER or SPA/CATH specimens.
All other growth was considered
NSG. DIAPER had a sensitivity of
100% and a specificity of 94%.
Grisaru-Soen et al.
(52), good
50 infants 0–18 mo of age suspected of
having UTIs or neonatal fever indicating
urine culture. Urine was collected by
SPA and by SUB.




Not given SG was defined as “pure growth” in
SPA or SUB specimens. All other
growth was considered NSG. SUB




192 non-toilet-trained children of 3 yr of
age from 2 emergency departments.
Urine was obtained by SUB. All children
had a positive microscopic examination








Not given SG was defined as 103 CFU/ml of a
single species in CATH specimens
and 105 CFU/ml of a single species
in SUB specimens. All other growth
was considered NSG. SUB had a
sensitivity of 83.3% and a specificity
of 91.1%.
a SUB, sterile urine bag collection; MSCC, midstream clean-catch collection; CATH, catheterization; SPA, suprapubic aspiration; DIAPER, collection from disposable diapers; SG,
significant growth; NSG, nonsignificant growth.
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communicate) the literature on diagnostic testing algorithms to
include nonanalytic variables, such as those measured in the in-
cluded studies reported here. This systematic review provides a
current and substantial literature base from which to begin inves-
tigations not only to address these gaps in current knowledge re-
lated to the effects of preanalytic factors on urine culture but also
to validate these best-practice recommendations in additional set-
tings and populations.
Associated Harms
Methods of collecting, storing, and preserving urine specimens for
the diagnosis of urinary tract infections have a critical influence on
culture results. Poorly collected or preserved specimens can be-
come easily contaminated with perineal, vaginal, and periurethral
flora, which can inhibit or obscure the presence of true urinary
tract pathogens. Conversely, the use of high concentrations of
boric acid as a preservative has been known to inhibit urinary
pathogens such as Escherichia coli and Klebsiella pneumoniae (65).
Midstream urine collection may be the preferred choice for col-
lection for most patients; however, there are patient populations
and clinical scenarios where a more invasive method of collection
is preferred (63). All of these issues can produce incorrect culture
results, misdiagnosis, especially in asymptomatic patients, poor
patient management, including the use of inappropriate or inef-
fective antibiotics, and potentially more complicated urinary tract
infection in the long term (2, 3).
Additional Benefits
Urine specimens that are appropriately collected, transported,
stored, and preserved benefit patients by producing more-accu-
rate culture results. In addition, such practices can provide benefit
to the laboratory by allowing technologists to focus on the
work-up of clinically significant pathogens rather than the growth
of contaminants. Urine cultures are often a major component of
the typical clinical microbiology workload (18); therefore, mini-
mizing the processing of poor-quality urine specimens can allow
FIG 5 Comparative differences in contamination levels between midstream collection with cleansing (MSCC) and midstream collection without cleansing (MS)
(A), midstream collection with cleansing and sterile urine bag collection (SUB) (B), midstream collection with cleansing and diaper collection (C), and sterile
urine bag collection and diaper collection (D) for infants and children.
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the laboratory to focus its resources in a more cost-effective man-
ner (22).
Economic Evaluation
Proper attention to the preanalytic phase of urine cultures
should decrease the number of contaminated urine specimens
processed by the laboratory. It may also decrease the time it
takes for microorganism identification and susceptibility test-
ing of pathogens in infected patients by reducing the number of
recollected specimens. Both of these scenarios would likely re-
duce health care costs for both patients and institutions by
reducing the time to appropriate targeted therapy and by mak-
ing more-effective use of laboratory and hospital resources.
However, no economic evaluation analyses were found for the
studies covered in this review.
Feasibility of Implementation
The methods of specimen collection and handling covered in
this review are feasible in all settings and patient populations
and are, in fact, commonly used in most medical environments
today. There are data showing the benefit of either refrigerating
or chemically preserving urine samples that are not immedi-
ately processed (28–37). Furthermore, midstream urine collec-
tion, with or without cleansing, is common practice for most
clinical settings and patient populations (38–62). For facilities
that have historically paid little attention to the preanalytic
aspects of urine culture, there may be some resistance on the
part of patients and staff that is typically associated with quality
improvement initiatives. Appropriate education regarding the
proper collection of urine specimens may be needed for both
patients and health care workers. The additional costs associ-
ated with chemical preservatives, such as boric acid, would also
need to be budgeted and justified.
Future Research Needs
The findings of this systematic review highlight the lack of recent
high-quality studies that evaluate components of the preanalytical
phase of urine culture. For example, the relative paucity of rigor-
ous studies evaluating methods of storage and chemical preserva-
tion of urine specimens is troublesome considering the wide-
spread use of these practices in many laboratories and a general
consensus among microbiologists as to their benefit. A large num-
ber of the studies suffered from small sample sizes, limiting the
precision of the results and reducing the likelihood that findings
are applicable across a larger population. Studies also used various
or unclear definitions of contamination or positivity thresholds,
making meta-analysis or qualitative summary analysis problem-
atic. Studies further suffered from missing data. For example,
most studies were cross-sectional or otherwise observational
(without randomization) in design, but many, particularly those
retrospective in nature, did not obtain or report the results of
samples from all patients obtained by all collection methods under
study. These inconsistencies lead to significantly uneven compar-
ison groups in some cases.
Future studies should strive for statistically sufficient sample
sizes, use common and clearly defined definitions of contamina-
tion and thresholds for positivity, and report accuracy results
across several common positivity thresholds to aid subsequent
meta-analysis. An example is the number of positive/negative
samples calculated if reviewers use a threshold of 104 versus
105 CFU per ml of urine. Studies should also be more rigorous in
design, include more randomized controlled trials, and ensure
paired sampling when possible in prospective or cross-sectional
studies. Moreover, for all methods under evaluation, patients
should have urine collected within a reasonable time frame, and
the time delay between collection and culture should be clearly
reported.
Finally, future studies should strive to obtain data on down-
FIG 6 Accuracy of midstream clean-catch (MSCC), sterile urine bag (SUB), or diaper collection compared with that of suprapubic aspiration (SPA) or
catheterization (CATH) for the diagnosis of urinary tract infection in children. TP, true positives; FP, false positives; FN, false negatives; TN, true negatives.
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stream patient-centered outcomes as influenced by different
methods of collection, preservation, or storage of urine that are
under evaluation. This broader measurement pool includes sys-
tem-oriented outcomes, such as time to targeted therapy, cost of
antibiotic use, number of UTI discharge diagnoses, or number of
Clostridium difficile cases avoided, such that the direct or indirect
impact of implementing a particular preanalytic practice can be
measured at the patient and organizational level. Information
provided in Appendix 2 can be used as a guide to organize and
plan studies as well as collect data for any quality improvement
project that examines preanalytical practices associated with urine
cultures.
Limitations
The LMBP systematic review method is compatible with other
standards of practice for systematic reviews (24) but includes
some unique elements, such as the rating of study quality. Rat-
ing study quality is based on attributes such as facility descrip-
tion, study setting and design, practice description, outcome
measures, and results. How studies are ultimately considered
for inclusion in the review depends on consensus assessments
that may be influenced by such things as a rater’s professional
background and experience. Indeed, several on-topic studies
were excluded because of limitations identified during quality
evaluation, mostly related to poor reporting of important
study, practice, or outcome details. This is likely somewhat
explained by the publication dates of many of the studies, with
several of both the excluded and included studies having been
published in the late 1960s. As is the case with most systematic
reviews, attempts were made to limit publication bias by solic-
iting unpublished data; however, no unpublished data were
submitted. Moreover, restricting the review to English-lan-
guage studies may also introduce bias.
Outside the limitations of the review process, there were a num-
ber of limitations in this review that affected the ability to draw
firm conclusions and make recommendations. Most of these lim-
itations were addressed above in the context of future research,
but additional limitations will be discussed here. The study set-
tings varied across included studies. Both inpatient and outpatient
settings were included, and the specific setting examined in each
study— emergency department, adolescent clinic, obstetric clinic,
etc.—may not be generalizable to other settings. Some settings
may be better equipped to perform certain collection methods or
to educate patients or parents on how to perform certain collec-
tion methods. Similarly, the patient populations under study var-
ied. Some studies included healthy asymptomatic patients, while
others included patients with more-severe conditions, such as spi-
nal cord injury patients. This too might affect the generalizability
of results. Within the body of evidence for children, studies often
included patients ranging in age from 0 to 16 years. Unfortunately,
there were not enough data available to properly stratify children,
such as infants, into smaller age groups, and because of this, results
may not be generalizable to patients of a specific age. Finally, as
discussed above, an important limitation was the variability in
positivity thresholds and definitions of contamination used across
studies. Although several guidelines have been developed to ad-
dress definitions of significant bacteriuria for culture (18, 63, 66–
68), these guidelines are not always consistent, and this lack of
consistency is reflected in the studies and results reported in this
review.
CONCLUSIONS AND RECOMMENDATIONS
A summary of the findings of this evidence-based review of urine
culture preanalytics can be found in Table 15. Conclusions are
categorized as “recommended,” “not recommended,” or “no rec-
ommendation for or against” and refer to studies of urine col-
lected by noninvasive methods:
1. No recommendation for or against is made for delayed pro-
cessing of urine that is stored at room temperature, refrig-









for or against due to
insufficient evidence
Delayed processing of urine stored at room temp vs
refrigeration vs boric acid
Fair Low 
Midstream urine collection from women with
cleansing
Good/fair High 
Midstream urine collection from women without
cleansing
Fair Low 
Midstream urine collection from women vs
collection by straight catheterization
Fair/good Low 
Midstream urine collection from men with cleansing Good/fair High 
Midstream urine collection from men without
cleansing
Fair Low 
First-void urine collection from men Good/fair High 
Midstream urine collection from men vs collection
by straight catheterization or suprapubic
aspiration
Fair Low 
Midstream urine collection from children with
cleansing
Fair/good High 
Midstream urine collection from children without
cleansing
Fair/good High 
Urine collection from children with sterile urine
bags and/or from diapers
Fair/good High 
Midstream urine collection from children vs
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erated, or preserved in boric acid due to insufficient evi-
dence. Data from nine studies receiving a “fair” quality
rating suggest that both refrigeration and boric acid ade-
quately preserve urine specimens for up to 24 h prior to
their being processed. Furthermore, data from three studies
receiving a “fair” quality rating suggest that urine held at
room temperature for more than 4 h should not be pro-
cessed due to overgrowth of both clinically significant and
contaminating flora. However, because the overall strength
of the body of evidence was rated as low, no recommenda-
tion for or against can be made due to insufficient evidence.
This does not preclude the use of refrigeration or chemical
preservatives in clinical practice. It does indicate, however,
that more systematic studies evaluating the utility of these
measures are needed.
2. If noninvasive collection is being considered for women,
midstream collection with cleansing is recommended,
but no recommendation for or against is made for mid-
stream collection without cleansing due to insufficient
evidence. Data from two studies, including one random-
ized controlled trial receiving a “good” quality rating and
three studies receiving a “fair” quality rating, show that
contamination rates are similar between specimens ob-
tained by midstream collection with and without cleans-
ing. The overall strength of this body of evidence was
rated as high. However, whether midstream collection
can be routinely used in place of straight catheterization
is unclear. Data from three studies, two with a quality
rating of “fair” and one with a rating of “good,” suggest
that clean-catch midstream urine collection is highly ac-
curate for diagnosing urinary tract infections in women;
however, because the overall strength of this body of ev-
idence was rated as low, no recommendation for or
against can be made.
3. If noninvasive collection is being considered for men, mid-
stream collection with cleansing is recommended and col-
lection of first-void urine is not recommended. No recom-
mendation for or against is made for collection of
midstream urine without cleansing due to insufficient evi-
dence. Data from two studies, one with a quality rating of
“good” and one with a rating of “fair,” found a large reduc-
tion in the level of contamination in specimens obtained by
midstream collection with cleansing compared to the level
of contamination after collection of first-void urine. This
body of evidence was rated as high. Although data from one
study rated as “good” quality found no difference in con-
tamination between midstream urine collected with and
that collected without cleansing, imprecision was large due
to the small event size, and no recommendation can be
made as to which method is superior. Whether midstream
collection can be used routinely in place of straight cathe-
terization or suprapubic aspiration is unclear. Data from
two studies receiving a “fair” quality rating suggest that
midstream collection with cleansing is highly accurate for
the diagnosis of urinary tract infections in men; however,
because the overall strength of the body of evidence was
rated as low, no recommendation for or against can be
made.
4. If noninvasive collection is being considered for children,
midstream collection with cleansing is recommended and
collection with sterile urine bags, from diapers, or mid-
stream without cleansing is not recommended. Data from
six studies, two with a quality rating of “good” and four
rated as “fair,” found large reductions in contamination in
midstream clean-catch urine specimens compared to con-
tamination after other noninvasive methods of collection.
This body of evidence was rated as high. Whether mid-
stream collection with cleansing can be routinely used in
place of catheterization or suprapubic aspiration is unclear.
Data from eight studies, two with a quality rating of “good”
and six rated as “fair,” suggest that midstream collection
with cleansing is accurate for the diagnosis of urinary tract
infections in infants and children and that midstream col-
lection with cleansing has higher average accuracy than
sterile urine bag collection (data for diaper collection was
lacking). However, the overall strength of evidence was low,
as multivariate modeling could not be performed; thus, no
recommendation for or against can be made due to insuffi-
cient evidence.
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Julie Gayken, Regions Hospital, St. Paul, MN; James Nichols,
Vanderbilt University Medical Center, Nashville, TN; Mary
Nix, Agency for Healthcare Research and Quality, Rockville,
MD; Milenko Tanasijevic, Brigham and Women’s Hospital,
Boston, MA; Sharon Geaghan, Stanford, University School of
Medicine, Stanford, CA; Christine Litwin, Georgia Health Sci-
ences University, Augusta, GA; Thomas Lorey, Permanente
Medical Group Regional Laboratory, Richmond, CA; Berna-
dette Mazurek Melnyk, The Ohio State University, Columbus,
OH; Anton Piskac, Methodist Health System, Omaha, NE; Jen-
nifer Rhamy, St. Mary’s Hospital, Oakbrook Terrace, IL; Chris-
topher Lee Roy, Brigham and Women’s Hospital, Boston, MA;
and Melissa Singer (ex officio), Centers for Medicare and Med-
icaid Services, Baltimore, MD.
APPENDIX 2
LMBP Evaluation of Preanalytic Practices for the
Contamination and Diagnostic Accuracy of Urine Cultures
Suggested guidance for future studies. This review identified
and rated practices associated with the collection, preservation,
and storage of urine specimens for culture and assessed the
impact of these preanalytic practices on the diagnostic accuracy
of urine culture microbiology. In theory, the design, descrip-
tion, methods, data collection, and analysis for any study
should be written and documented so that other investigators
can reproduce exactly the same study in their laboratory, with
their results validating or verifying those of the original study.
The following organizational plan with instructions can be
used as a guide for quality improvement project design, imple-
mentation, and evaluation of preanalytic practices associated
with urine cultures. Figure A1 shows a form for use in collect-
ing data for any QI project that examines preanalytical prac-
tices associated with urine cultures.
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Background Information
1. Problem/quality issue description.
A. Practices and equipment. Describe what preanalytic
practices associated with the collection and preservation
of urine for culture were studied and exactly how spec-
imens were collected. Include examples of educational
material handed to patients or displayed on walls in ar-
eas where patients were seen.
i. Collection. Indicate whether specimens were ob-
tained by midstream clean-catch collection versus
midstream collection without cleansing, midstream
clean-catch collection versus straight catheter collec-
tion and/or suprapubic aspiration, midstream col-
lection without cleansing versus straight catheter
collection and/or suprapubic aspiration, midstream
collection with or without cleansing versus first-void
urine collection, midstream collection with or with-
out cleansing versus diaper collection and/or sterile
urine bag collection, or other means.
ii. Preservation/storage/transport. Include the time
from collection of the specimen to the addition of
preservative and how long it took the specimen to
reach the lab after collection, as well as how long it
took from receipt in the lab to setup of culture. Indi-
cate whether boric acid, glycerol boric acid, or sorbi-
tol boric acid was used as a preservative, whether the
specimen was stored in a refrigerator or at room tem-
perature, and any other relevant preservation or
storage information.
B. Population under study and age ranges. Include physical
differences which may affect the collection of the speci-
men, such as physical disability, the presence of a fore-
skin in males, the presence of diapers, etc. With infants
and neonates, consider tighter age ranges, such as 0 to 2,
2 to 4, etc.
C. Collection personnel. Indicate whether the specimen
was collected by a nurse, nurse’s aide, physician, special-
ized urine collection team, lab technologist or techni-
cian, or other staff member.
2. Submitter(s) and organization affiliation. For additional
FIG A1 Form for use in collecting data for any QI project that examines preanalytical practices associated with urine cultures.
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questions concerning the quality improvement (QI) study,
contact information is required.
3. Funding source(s). Refer to the chart in Fig. A1. Check all
boxes that apply.
QI Project/Study
4. QI project study design/type. With similar patient popula-
tions, describe the methods/approaches used for your proj-
ect with regard to age, sex, ethnicity, and/or diagnosis to
limit bias.
A. Pre- and postimplementation. Observations are made
before and after the implementation of an intervention.
B. Split implementation design. Indicate whether multiple
sites were used to conduct the QI study.
C. Case-control study. Indicate whether the study com-
pared subjects with a specific outcome of interest (cases)
with subjects from the same source population but with-
out that outcome (controls) to examine the association
between the outcome and prior exposure (for which
there was an intervention).
D. Cross-sectional associations. Collect information on in-
terventions (past or present) and current health out-
comes, i.e., those that are restricted to health states, for a
group of people at a particular point in time, to examine
associations between the outcomes and exposure to in-
terventions.
E. Cohort. A defined group of people (the cohort) is fol-
lowed over time to examine associations between differ-
ent interventions received and subsequent outcomes.
F. Randomized assignment. Patients are randomly se-
lected to receive the intervention practice or the com-
parator practice.
G. Other study design used in this QI project. Describe the
study design selected.
5. Facility description. Provide a complete description of the
facility type and the number of beds (or patients if the facil-
ity is an outpatient facility).
6. Study setting. Select the unit(s) within the facility where the
practice was implemented, e.g., inpatient, outpatient,
emergency department, pediatric unit, neonatal intensive-
care unit, or other.
7. Overall project/study time frame. Record the start and end
dates for the new and usual practices; if pilot testing was
conducted, include start/end dates for pilot testing of the
new practice. Note that this is not the same as the QI study
period but rather the dates during which these practices
were being used in the unit(s) in which the study was done.
Put “NA” If some dates are not available.
8. Sampling strategy. The sample size is the number of pa-
tients/observations used for the usual (current) practice
and the alternate practice. Use the largest available sample
size at each time of measurement. For results to be reliable,
the implemented practice should be the only thing affecting
the results. It is the largest sample size available that repre-
sents only the results of the usual practice and the largest
sample size that represents only the results of the alternate
practice. Describe your sample set (tests, patient specimens,
patients, or type of patient specimens) and the sample size
(example: prior to [usual] practice [15,000 patient speci-
mens tested] and after [alternate] practice [13,200 patient
specimens tested]).
Optimally, a power analysis should be performed prior to con-
firmation of sample size. Statistical power is the probability of
concluding that there is a difference when there is, in fact, a dif-
ference between your standard method and your new method
(i.e., the probability that your study will detect a difference, given
that one truly exists). An example of a nomogram for sample size
calculation can be found in reference 69.
Statistical power is the probability of concluding that there is a
true and significant difference between your comparator and in-
tervention, thus minimizing type I and type II errors (sensitivity
and specificity).
For sample description, refer to the following list.
A. Random sampling. Subjects (patients) are selected for
study inclusion using a formal random selection process
applied to the census.
B. Convenience sampling. Some subset of the census is se-
lected since it is easy to access. For example, using only data
from records of patients whom you can easily reach would
be a convenience sample.
C. Census sampling. All participants within a specified time
period or location are used in census sampling.
D. Other. Describe whether you are using a different sampling
method. If you are using anything other than random sam-
pling, convenience sampling, or census sampling, you need
a statistician to identify sampling strategy.
QI Practice
9. Describe the original (usual) practice. Describe the origi-
nal (usual) practice(s) that will be compared to the new
practice/policy/technology implemented.
10. Describe the alternate/intervention (new) practice. De-
scribe the new practice/policy/technology, including the
characteristics and components for ongoing day-to-day
operations.
11. Intervention duration dates (pilot, pre/postintervention,
etc.). Record the start and end dates for the pilot testing,
usual practice, and new practice. This is the date on which
the particular QI project was implemented and the date on
which it ended. Note that a pilot test may not have been
used in this study. There should be no gaps in the QI proj-
ect data collection once it begins.
12. Resource requirements/costs. Describe the requirements
and costs for starting and sustaining the new practice dur-
ing the study. If this information is not available, list “not
known.” Do not list the cost of the practice that is currently
being used to do patient testing.
Outcome Measures
13. Outcome measure(s). Describe how the impact of the
practice was measured. Provide the specific outcome(s)
and corresponding specifications/definitions used to as-
sess or track the impact of the practices implemented. An
example is a description of how urine culture contamina-
tion rates were affected or how they had an impact on the
diagnostic accuracy of urine culture.
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14. Recording method. Describe each method used to collect
data and to which practice (usual or new) it refers.
15. Potential sources of bias. Bias is the tendency to produce
results that depart systematically from the “true” results.
Bias is any nonrandom factor in the conduct of a study that
can influence the results of a study.
A. Selection bias. Selection bias occurs when studies are
conditioned on (that is, they differentially select for)
common effects of the exposure and the outcome.
Selection bias occurs after exposure and arises when
the associations between exposure and outcome are
different for those who participate and those who do
not participate in a study (i.e., all those who are the-
oretically eligible). This bias includes inappropriate
selection of controls in a case-control study, differ-
ent losses to follow-up for groups being compared
(attrition bias), incidence/prevalence bias, nonre-
sponse bias, and inclusion or exclusion of specific
groups for study.
B. Performance bias. Performance bias includes system-
atic differences in the types of care provided to partic-
ipants and protocol deviations. Examples include con-
tamination of the control group with the exposure or
intervention, unbalanced provision of additional in-
terventions or cointerventions, a difference in cointer-
ventions, and providers and participants not being ad-
equately blind to the study results.
C. Detection bias. Detection bias includes systematic dif-
ferences in outcome assessments among groups being
compared. Reasons for this bias include misclassifica-
tion of the exposure, intervention, covariates, or out-
comes because of varying definitions, timings, diag-
nostic thresholds, and memories of an event; assessors
not being adequately blind to the study results; and
faulty measurement techniques. Erroneous statistical
analysis might also affect the validity of effect estimates.
D. Confounding bias. Confounding bias is the presence
of systematic differences between baseline charac-
teristics of the groups that arise when patient prog-
nostic characteristics, such as disease severity or co-
morbidity, influence both treatment source and
outcomes. Confounders are the common cause for
intervention and exposure; they occur before expo-
sure. Confounding by indication can occur from
self-selection of treatments or physician-directed se-
lection of treatments.
E. Reporting bias. Reporting bias is the presence of sys-
tematic differences between reported and unre-
ported findings (e.g., differential reporting of out-
comes or harms, incomplete reporting of study
findings, and potential for bias in reporting through
source of funding).
Results/Findings
16. Results/findings as related to study design/outcome
measure. For each outcome provided, summarize the
results/findings of the study/project related to the prac-
tice. Provide the total number of observations (sam-
ples) on which the results are based and statistical tests
results, if a statistical analysis was performed. Include
findings related to cost savings or shortened length of
stay, if applicable.
17. Data analysis with regard to statistics. Describe the sta-
tistic used to measure the strength of association or the
statistical measures of the performance of classification
tests (e.g., sensitivity, specificity). Examples are as fol-
lows.
A. With first-void urine collection, 10 urine samples are
contaminated per 100 urine cultures performed (10%
contamination rate).
B. With midstream clean-catch urine collection, 3 urine
samples are contaminated per 100 urine cultures per-
formed (3% contamination rate).
C. The odds ratio is 0.28 (3/10/97/90).
18. Data analysis with regard to significance. Describe the tests
of significance. Include calculations of the statistical sig-
nificance of a difference between the usual practice and
the alternate practice on the measured outcomes listed in
item 14.
19. Barriers to implementation. Describe any outside activi-
ties occurring at the same time as the project, such as staff
changes or new policy, that may have influenced the re-
sults of the project. Describe any barriers that directly im-
pacted the project.
20. Study dates completed or report submitted. Dates should
include the date that the study was completed, the date it
was reported (and where it was reported), and the date it
was submitted to the LMBP initiative.
APPENDIX 3
Refer to Tables A1 to A4 for evidence summaries of results for
storage (refrigeration versus room temperature) and boric acid
preservation of urine, contamination and diagnostic accuracy of
urine collected from women, contamination and diagnostic accu-
racy of urine collected from men, and contamination and diag-
nostic accuracy of urine collected from children.
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TABLE A1 Evidence summary table for storage (refrigeration versus room temperature) and boric acid preservation of urinea
Bibliographic information Study Practice Outcome measures Results/findings
Authors: Hindman et al. (30)
Title: Effect of Delay on the
Culture of Urine
Yr: 1976








Time period: not given
Population/sample: 100
random specimens of urine
submitted for culture and
received by the laboratory
within 2 h of the stated time
of collection
Comparator: not reported
Study bias: sample size
Description: evaluation of the impact
of time delay between collection
and culture of urine samples
Duration: not reported
Training: not reported
Staff/other resources: not reported
Cost: not reported
Description: to determine the impact of
delay in culturing urine specimens at 2
h, 4 h, and at 6 h postcollection
Recording method: comparison of culture
colony counts, and IDs between the
different time periods
Type of findings: comparison
Findings/effect size: No growth was
observed in 53 of the specimens; 47
cultures were positive. Changes in
counts exceeding 1 log10 or greater were
observed in 15 of the specimens.
Statistical significance/tests:
Results/conclusion bias: delays of greater
than 2 h in processing specimens may
produce results which may cause errors
in diagnosis
Total quality rating (10-point
maximum): 6, fair
Total for study (3-pt.
maximum): 2 (1 point
subtracted due to small
sample size)
Total for practice (2-pt. maximum):
1 (1 point was subtracted, as
practice was not sufficiently
described)
Total for outcome measures (2-pt.
maximum): 2
Total for results/findings (3-pt. maximum):
1 (not powered to make large-scale
recommendations)
Authors: Lum and Meers
(31)
Title: Boric Acid Converts













Time period: not reported
Population/sample: 175 urine
specimens collected from
patients 2 yr old
Comparator: nonpreserved
urine samples
Study bias: criteria for patient
selection not given
Description: Samples were collected
by midstream void and divided
into an unpreserved portion and a
portion placed in BA.
Duration: 6 mo
Training: nurses trained on how to
split and preserve samples
Staff/other resources: not reported
Cost: not reported
Description: determination of the ability of
boric acid to preserve the quantity and
quality of microbial organisms in urine
specimens
Recording method: comparison of colony
counts and organism significance in the
2 portions over 0, 4, 24, and 48 h
Type of findings: comparison
Findings/effect size: Preserved samples
showed fewer positive cultures over time
than unpreserved samples; organism IDs
were similar in both preserved and
unpreserved samples.
Statistical significance/tests: not reported
Results/conclusion biases: limited patients
enrolled and only those that were
considered to have infections were
enrolled
Total quality rating (10-pt.
maximum): 6, fair
Total for study (3-pt.
maximum): 1 (patient
selection criteria not well
defined)
Total for practice (2-pt. maximum):
2
Total for outcome measures (2-pt.
maximum): 2
Total for results/findings (3-pt. maximum):
1 (no statistical analysis, trending data
only; no discussion of inhibitory effect
of borate at time zero)
Authors: Porter and Brodie
(28)
Title: Boric Acid Preservation
of Urine Samples
Yr: 1969








Time period: not reported
Population/sample: 130
midstream urine samples
collected in sterile tubes
Comparator: unpreserved urine
Study bias: no selection criteria
indicated
Description: comparison of urine
transport using midstream
samples shipped without
preservative at room temp, on ice,
and with boric acid preservative
Duration: not reported
Training: not reported
Staff/other resources: not reported
Cost: 0.07 pence/specimen
Description: comparison of results of
bacteriological culture and microscopic
examination of urine samples
transported over a distance either in a
dip inoculum transport medium, an ice
box, or BA preservative
Recording method: results recorded as SG,
DS, or NSG
Type of findings: comparison
Findings/effect size: BA preserved the ice
box-transported urine samples. Findings
were similar. Increased numbers of
bacteria were found in unpreserved
urine compared to numbers in BA-
preserved urine.
Statistical significance/tests: not reported
Results/conclusion bias: Specimens
preserved in BA for 3 days gave
misleading results
Total quality rating (10-pt.
maximum): 6, fair
Total for study (3-pt.
maximum): 2 (selection
criteria not reported)
Total for practice (2-pt. maximum):
2
Total for outcome measures (2-pt.
maximum): 1 (measurements do not
fully address goals of study)
Total for results/findings (3-pt. maximum):
1 (small sample size, lack of statistical
analysis)
Authors: Gillespie et al. (29)














Time period: not reported
Population/sample: consecutive
samples of urine (n  1,175)
from 643 females and 149
males. 408 were excluded for
1 of the following reasons:
the time of collection was
unknown, they were catheter
specimens, the vol was 10
ml, the age of the patient was
16 yr, or the reason was
unstated.
Comparator: not reported
Study bias: none noted
Description: All samples were
cultured within 8 h of specimen
collection. Thereafter, every
sample was kept at room temp
overnight and then recultured the
following morning. The
specimens were processed by a
semiquantitative method for the
detection of bacteria. After
overnight incubation, the no. of
colonies growing was counted and
the concn of organisms in the
original sample was calculated.
The culture plates resulting from
immediate processing and those
which had been cultured after
overnight storage were read





clinical indications for specimen
referral. All samples were
processed by the same Medical
Laboratory Scientific Officer.
Cost: not reported
Description: Bacterial culture results were
recorded according to the colony counts
observed. No growth, growth of 104
organisms/ml, and mixed growth at any
concn were not regarded as significant.
Growth of between 104 and 105 CFU/ml
in pure culture was regarded as
equivocal. A result of 105 CFU/ml in
pure culture was assessed as being
significant and indicating bacterial
infection. All organisms from growth
assessed as significant or equivocal were
identified to the species level using
standard microbiological methods.
Recording method: The computer software
package EPI-INFO (version 5; Centers
for Disease Control and Prevention,
Epidemiology Program Office, Atlanta,
GA, USA) was used to analyze the
results. The odds ratio was used to
determine the statistical significance of
the results.
Type of findings: comparison
Findings/effect size: After overnight delayed
culture, the results were altered in 16% of
samples and the clinical interpretations of
these findings differed in 8% of specimens.
In 28 samples (3.5%), the bacterium
isolated upon initial culture was not the
same as that obtained by culture after
overnight storage.
Statistical significance/tests: The difference
in the no. of samples for which the
interpretation changed from a
significant to a nonsignificant culture
result after overnight storage and the no.
of samples for which the interpretation
was altered from a nonsignificant to a
significant culture result was clinically
significant (odds ratio  73.89; 95% CI,
41.28 to 133.01). A slight increase from
106 to 117 in the no. of samples
recorded as contaminated was also
observed; this does not achieve statistical
significance (odds ratio  0.89; 95% CI,
0.66 to 1.20).
Results/conclusion biases: none noted
(Continued on following page)
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TABLE A1 (Continued)
Bibliographic information Study Practice Outcome measures Results/findings
Total quality rating (10-pt.
maximum): 7, fair
Total for study (3-pt.
maximum): 2 (no
control group)
Total for practice (2-pt. maximum):
1 (initial plating delay)
Total for outcome measures (2-pt.
maximum): 2




Title: Evaluation of the BD
Urine Culture Kit
Yr: 1981








Time period: not reported
Population/sample: The
study was conducted in












Study bias: none noted
Description: In the first phase, a
sample of the specimen was
drawn into the BD urine culture
kit for transport at room temp,
and a sample of the remaining
specimen was stored and
transported to the laboratory in
a sterile tube at 5°C. The
samples in both tubes were
processed for semiquantitative
culture. The BD kit (preserved
urine) was stored at room temp
and recultured quantitatively
after 24 and 48 h. In the second
phase, urine was collected into a
sterile tube and transported to
the laboratory, where it was
cultured and then stored under
refrigeration. Cultures were
examined after incubation for
18 to 24 h. Urine specimens
yielding 10,000 CFU of
bacteria other than Escherichia
coli/ml were selected for study
by drawing 5 ml of the
refrigerated specimen from a
nonsterile paper cup into the
BD kit. Cultures of both the
original refrigerated specimen
and that just drawn into the BD
kit were then made within the
hour. The BD kit (preserved
urine) was then stored at room







Description: comparison of colony counts
in refrigerated specimens vs specimens
stored in BD urine culture kit
Recording method: routine lab reports
Type of findings: comparison
Findings/effect size:
1. There was 98% agreement between the
results for initial cultures of original
urine yielding 105 CFU/ml and
results for preserved urine.
2. Agreement between the results for
initial cultures of original urine
yielding 104 to 105 CFU/ml and those
for preserved urine was 79.3% in phase
1 and 100% in phase 2. The no. of
specimens yielding 104 to 105 CFU/ml
was too small to determine whether
the apparent difference in agreement
between the results for the 2 phases of
study was significant or simply due to
random sampling error.
3. Agreement between the results for
initial cultures of original urine
yielding 105 CFU/ml and the results
for urine preserved for 24 h was 87.3
and 82.6% in phases 1 and 2,
respectively; however, the agreement
between results for initial cultures of
original urine yielding 104 to 105 CFU/
ml and urine preserved for 24 h was
only 55.2 and 45.8% in phases 1 and 2,
respectively. By 48 h, there were
substantial discrepancies between the
no. of CFU/ml of the original
specimen and the no. of CFU/ml of the
preserved specimen.
Statistical significance/tests: not reported
Results/conclusion biases: none noted
Total quality rating (10-pt.
maximum): 7, fair
Total for study (3-pt.
maximum): 2 (no. of
patients not reported)
Total for practice (2-pt.
maximum): 2
Total for outcome measures (2-pt.
maximum): 1 (recording method not
well described)
Total for results/findings (3-pt. maximum):
2 (no statistical analysis performed)
Authors: Hubbard et al. (34)
Title: Comparison B-D Urine
Method with a
Standard Culture
Method and the MS-2
Method
Yr: 1983
Publication: J Clin Microbiol
Affiliations: University of
Michigan Medical


















Description: In phase 1, 100
samples routinely submitted to
the microbiology lab were
divided into a refrigeration
group and a BD tube group.
Colony counts were compared
at 0, 5, and 24 h. Samples were
also tested using the MS-2 urine
screening system. In phase 2,
158 samples known to be
positive by routine culture and
MS-2 were retested by routine
culture and MS-2 at 0 and 24 h.
In additional experiments, MS-2
growth curves are shown for




Staff/other resources: not reported
Cost: not reported
Description:
1. Comparison of growth levels by
determining colony counts in
refrigerated specimens and BD tube
urine samples at 0, 5, and 24 h.
2. Comparison of percentages of
positivity in known positive samples
among refrigerated specimens vs BD
tube urine samples at 0 and 24 h.
3. Growth rates were determined for a
limited sample of known-positive
specimens.
Recording method: routine lab reports
Type of findings: comparison
Findings/effect size: In phase 1, negative
cultures and those that had either
contaminants or 105 CFU/ml
exhibited no change. However, there
were several discrepancies between
refrigerated specimens and BD tube
specimens for the 26 positive urine
specimens containing 105 CFU/ml.
The refrigerated specimens showed
no change in colony counts when
cultured at 0, 5, and 24 h. The BD
tube specimens showed decreases in
colony counts below 105 CFU/ml for
96% (0 h), 88% (5 h), and 85% (24
h) of cultures. In phase 2, MS-2
detected about the same no. of
refrigerated specimens (91.1%) at 24
h as did the standard culture method
(93.0%). In contrast, 17.1% of the
BD tube specimens were not detected
by the MS-2 at 0 h, and 36.7% were
missed by MS-2 after being held 24 h
in the BD urine transport tube.
Statistical significance/tests: not reported
Results/conclusion bias: BD tubes were
inoculated in the laboratory and not
at the bedside
Total quality rating (10-pt.
maximum): 6, fair
Total for study (3-pt.
maximum): 1 (BD




Total for practice (2-pt.
maximum): 2
Total for outcome measures (2-pt.
maximum): 1 (no head-to-head
comparison of sensitivity/specificity for
routine and BD samples)
Total for results/findings (3-pt. maximum):
2 (no statistical analysis performed)
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upon receipt in the
laboratory





1. Each specimen was cultured
four times on 5% sheep blood
agar and MacConkey agar
biplates by the surface streak
technique with a calibrated
0.001-ml platinum loop at the
intervals described below.
2. Well-mixed urine plated
directly from the sterile
container according to routine
laboratory procedures served
as the initial reference culture
(plate 1) for all subsequent
comparisons.
3. A portion of urine then was
poured into a nonsterile,
plastic-lined paper cup, drawn
into a BD urine culture kit,
mixed briefly in a vortex
mixer, and recultured (plate
2).
4. The original specimen was
refrigerated (4 to 100°C) for 18
to 24 h, and the urine
transport tube was left on the
laboratory bench at room
temp (25 	 20°C) before




Staff/other resources: not reported
Cost: not reported
Description: Urine specimens that grew
105 CFU/ml of a potential urinary
tract pathogen/ml in pure culture were
considered positive. Cultures growing
105 CFU/ml or a mixture of
organisms were considered negative.
Colony counts were recorded as 105,
104–105, or 103–104 CFU or no growth.
A single colony was classified as no
growth.
Recording method: not reported
Type of findings: observational
Findings/effect size:
1. 88 reference cultures grew 105 CFU/
ml of a single potential urinary tract
pathogen. Culture results were
comparable after refrigeration or
chemical preservation for 24 h; both
methods detected 82 of the 88 positive
reference cultures (93.2%). The
discrepancies mostly consisted of
growth of the pathogen in addition to
growth of a few Gram-positive
urogenital tract contaminants on
comparison plates but not in the
reference cultures.
2. A total of 912 reference cultures,
including 349 plates that showed no
growth, were negative. Of the 912
specimens, only 1 was falsely positive
after 24 h of refrigeration, and none
was falsely positive after chemical
preservation. Bacterial counts of the
predominant microorganisms in the
urine specimens were preserved by
either refrigeration or the boric acid-
glycerol-sodium formate solution and
agreed within 1 log CFU/ml with the
reference culture 98% of the time.
Statistical significance/tests: not reported
Results/conclusion biases: none reported
Total quality rating (10-pt.
maximum): 7, fair
Total for study (3-pt.
maximum): 1
(specimens were not
preserved at the point
of collection)
Total for practice (2-pt.
maximum): 2
Total for outcome measures (2-pt.
maximum): 2
Total for results/findings (3-pt. maximum):
2 (no statistical analysis performed)
Authors: Southern and
Luttrell (36)
Title: Use of the Becton,
Dickinson Urine Culture
Tube with the Abbott MS-






of Texas Health Science

















clinic for prenatal care.
Many patients had
symptoms referable to








Description: Patients voided urine
that was collected in midstream
clean-catch fashion in a sterile
container. Immediately, a
sample of urine was drawn into
a Becton, Dickinson urine
culture kit tube and another
into a sterile screw-cap tube.
Both tubes were sent to the
laboratory as soon as possible. If
transport could not be
accomplished within 20 min,
the sterile conventional tube was
refrigerated. In the laboratory,
both tubes were streaked with a
calibrated quantitative loop
onto eosin-methylene blue agar,
Columbia nalidixic acid blood
agar, and blood agar. Each tube
was also inoculated into an
Ampvette of the Abbott MS-2





collection supervised by nursing
personnel
Cost: not reported
Description: All specimens not determined
to be positive by the MS-2 within 6 h
were reported as negative. The numbers
and types of organisms isolated on each
plate for each specimen were recorded.
If the colony count exceeded 50,000/ml
for Gram-positive cocci or 100,000/ml
for Gram-negative bacilli (unmixed
cultures), then all isolates were
identified and antimicrobial
susceptibility testing was performed.
The Becton, Dickinson tubes were held
an additional 24 h at room temp, and a
delayed quantitative culture was done
for comparison with the original.
Recording method: not reported
Type of findings: comparison
Findings/effect size:
1. 124 urine specimens were positive in
both conventional and Becton,
Dickinson tubes. Escherichia coli (n 
72), Klebsiella pneumoniae (n  20),
Enterobacter cloacae (n  8), Proteus
mirabilis (n  4), group B
streptococcus (n  12), and
enterococcus (n  8) were isolated.
2. Times for detection of positive urine
samples were similar for both
preserved and unpreserved samples.
Delayed cultures had significant
numbers of false-positive results.
Antimicrobial susceptibility results did
not appear to be influenced by Becton,
Dickinson tube transport. MS-2
cannot adequately discriminate
cultures containing 50,000 CFU/ml
of urine.
Statistical significance/tests: not reported
Results/conclusion bias: MS-2 system could
not detect colony counts below 102
CFU/ml
Total quality rating (10-pt.
maximum): 7, fair
Total for study (3-pt.
maximum): 2 (sample
selection bias)
Total for practice (2-pt.
maximum): 2
Total for outcome measures (2-pt.
maximum): 1 (recording method not
described)
Total for results/findings (3-pt. maximum):
2 (no statistical analysis performed)
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Author: Weinstein (37)

















Funding: supported in part






Time period: not reported
Population/sample: A




obtained in a sterile
cup. 7 specimens were
inadvertently discarded
after initial plating in
the laboratory; thus,
there were 862 paired









Study bias: not reported
Description: Immediately after a
specimen was collected, the
responsible nurse obtained 2
samples with a disposable plastic
transfer device (BD urine
culture kit; Becton, Dickinson
Vacutainer Systems).
Throughout the study period, 1
sample was obtained in the
commercially available
Vacutainer tube containing an
LQ solution consisting of boric
acid, glycerol, and sodium
formate. During the latter half
of the study period, a second
sample was obtained in a
Vacutainer tube that contained
an LY similar in content to the
LQ, except that sorbitol was
substituted for glycerin to
facilitate lyophilization. The
sterile cup and preserved
samples were transported to the
laboratory by hospital courier,
and an attempt was made in
each case to determine the
elapsed time between obtaining
the specimen and plating it for
culture.
Duration: 6 mo
Training: nurses instructed on
urine collection
Staff/other resources: not reported
Cost: not reported
Description: Samples preserved in either
LQ or LY were cultured only if they
contained 0.4 ml of urine. After initial
plating (time zero), the sample in the
sterile cup was refrigerated (4 to 10°C)
for 18 to 24 h; samples preserved in
either LQ or LY were kept at room temp
in the laboratory (21 to 24°C) for the
same period of time. The following
morning, all samples were recultured.
All isolates obtained from urine cultures
growing 104 CFU of a single
microorganism/ml in pure culture were
identified by standard biochemical
methods at least to the genus level. Any
culture which grew 105 CFU/ml of a
single microorganism in pure culture
was considered to be positive for the
purpose of data analysis.
Recording method: not reported
Type of findings: comparison
Findings/effect size:
1. At the time of initial plating, 106 of 111
(95.5%) specimens that were positive
after conventional transport were also
positive in liquid preservative. After a
24-h holding period, agreement was
91.4% (96 of 105). At the time of initial
plating, agreement between results
obtained by the conventional method
and those obtained by using lyophilized
preservative was 96.9% (63 of 65); after
24 h, agreement was 92.4% (61 of 67).
2. The proportions of urine cultures
showing no change in quantitative
growth between the time of initial
plating and repeat plating at 24 h were
virtually identical for all 3 processing
methods (83.6 	 0.9%).
3. After the 24-h holding period,
specimens processed in lyophilized
preservative were less likely to show
diminished quantitative growth than
were specimens processed
conventionally or in liquid preservative
but were more likely to show an
increase in growth of 1 log.
Nonetheless, the apparent lack of
toxicity of lyophilized preservative may
make it preferable to the currently
available liquid preservative.
Statistical significance/tests: not performed
Results/conclusion bias: impact of a 24-h
delay in specimen processing was not
assessed
Total quality rating (10-pt.
maximum): 7, fair
Total for study (3-pt.
maximum): 3
Total for practice (2-pt.
maximum): 2
Total for outcome measures (2-pt.
maximum): 1 (recording method not
reported)
Total for results/findings (3-pt. maximum):
1 (no statistical analysis was
performed; a specimen preserved for
longer than 24 h was not assessed)
Authors: Wright et al. (32)
































Study bias: none noted
Description: Preserved urine was
screened with 6 urine screen
systems: Chemstrip LN,
Autobac IDX, BacT Screen,
bioluminescence, and the AMS.
Fresh specimens received by the
laboratory were first
quantitatively cultured and
screened with the BacT Screen.
Screen-positive samples were
then added to 3 urine
preservation systems, held for 24
h at room temp, and then
recultured and retested in each
of the 6 urine screens.
Duration: not reported
Training: not reported
Staff/other resources: not reported
Cost: not reported
Description: 3 commercially available urine
transport systems were tested for their
effect on rapid urine-screening
procedures and organism
identifications: a GBF system, a
lyophilized SBF system, and a 5.5% BA
system.
Recording method: not reported
Type of findings: comparison
Findings/effect size:
1. Quantitative cultures of urine
specimens preserved for 24 h showed
little or no change in the no. of viable
organisms recovered.
2. Quantitative discrepancies ranged
from 0% for urine preserved with GBF
and tested by AMS or leukocyte
esterase to 21% for urine samples in
the same preservative tested by
bioluminescence or nitrate.
3. Up to 62% of the organism
identifications made from preserved
urine specimens tested by the AMS urine
card were in error.
Statistical significance/tests: not performed
Results/conclusion biases: impact of a
24-h delay in specimen processing
was not assessed
Total quality rating (10-pt.
maximum): 6, fair
Total for study (3-pt.
maximum): 3
Total for practice (2-pt.
maximum): 1 (practice poorly
described)
Total for outcome measures (2-pt.
maximum): 1 (recording method not
reported)
Total for results/findings (3-pt. maximum):
1 (no statistical analysis performed)
a For scoring information, see Christenson et al. (24). IDs, identifications; pt., point; 95% CI, 95% confidence interval; SG, significant growth; DSG, doubtful significant growth;
NSG, nonsignificant growth; LQ, liquid preservative; LY, lyophilized preservative; AMS, Automicrobic system; GBF, glycerin-boric acid-sodium formate; SBF, sorbitol-boric acid-
sodium formate; BA, boric acid.
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Authors: Blake and Doherty
(38)













grant 5 K23 AI01750
from the National










an adolescent clinic were
assigned to either the
standard collection group
(n  25) or the sequential
collection group (n  25).
Participant ages ranged
from 14 yr to 23 yr (mean,




Study bias: none noted
Description: Participants were assigned to
either the standard collection group or
the sequential collection group.
Standard collection group (n  25)
participants were instructed on the
collection of an MSCC urine sample.
They were told to cleanse their
perineum with a towelette, pass the
first part of their urine into the toilet,
and collect the next part of their urine
in a sterile container. Sequential-
collection group (n  25) participants
were instructed not to cleanse their
perineum and to collect 2 sequential
urine samples by voiding 10 to 20 ml
into the first container and the
remainder into a second sterile
container. Midstream urine specimens
from both groups were transported to
the laboratory for culture.
Duration: 2 mo
Training: patient instructions given











Type of findings: comparison of colony
counts
Findings/effect size:
1. No culture grew 10,000 colonies
of a pathogenic bacterium. 11
(44%) of the exptl group samples
and 9 (36%) of the control samples
grew 10,000 colonies of perineal
bacterial flora (chi square  0.33;
P  0.56). Participants’ previous
experience collecting midstream
urine was not associated with less
bacterial contamination.
2. While the mean rating for comfort
with the collection method was
higher in the standard collection
group than in the sequential-
collection group, the mean ratings
for ease of collection were not
significantly different between
groups.
3. A relatively large proportion of
cultures showed perineal-flora
growth in both the sequential-
collection and standard-collection
groups, suggesting that perineal
cleansing does little to reduce
contamination.
Statistical significance/tests: chi-square,
Fisher’s exact test, and Spearman
correlation were used to compare
the groups. Data analyses were
performed using SPSS for Windows
version 12.0 (SPSS Inc. Chicago,
IL).
Results/conclusion biases: small sample
size, use of asymptomatic patients
only
Total quality rating (10-pt.
maximum): 7, fair
Total for study (3-pt.
maximum): 2 (small sample
size, study setting)
Total for practice (2-pt. maximum): 1





Total for results/findings (3-pt.
maximum): 2 (small measurement
period and no. of patient samples
in analysis)
Author: Bradbury (42)
Title: Collection of Urine
Specimens in General
Practice: To Clean or
Not To Clean?
Yr: 1988


















Time period: not reported
Population/sample: A total of
316 urine specimens were
collected from 158 female
patients suspected of having
UTIs and from 158
controls. The study group
comprised any female aged
16–75 yr who presented
with symptoms of




surgery with no urinary
tract symptoms. The
women were randomly
allocated to 1 of the 2
methods of urine collection.
Comparator: clean-catch
collections
Study bias: control group
without symptoms of UTI
Description: Those using the cleaning
method were instructed to wash their
hands and then use the 3 cotton wool
swabs provided to cleanse the genital
area with soap and water. They were
told to part the labia and wipe from
front to back 3 times using a clean
swab each time. Keeping the labia
parted they passed some urine into the
toilet and then caught some urine in a
sterile container containing 0.4 g of
boric acid as a preservative.
Participants not using the cleaning
method were instructed simply to pass
some urine into the toilet, stop and
then catch the next urine in a sterile
BA container
Duration: 16 mo
Training: each patient was given written
collection instructions






classified as definite or
equivocal infection




Type of findings: comparison of culture
results, calculation of
contamination rates
Findings/effect size: A total of 316
specimens, 158 from women with
symptoms of cystitis and 158 from
asymptomatic controls, were
examined. No significant
differences were found in the
numbers of contaminated or
unreliable results between the
specimens collected with and
those collected without
preparatory cleansing.
Statistical significance/tests: not reported
Results/conclusion biases: none reported
Total quality rating (10-pt.
maximum): 7, fair
Total for study (3-pt.
maximum): 1 (selection of
control group,
generalizability)
Total for practice (2-pt. maximum): 2 Total for outcome
measures (2-pt.
maximum): 2
Total for results/findings (3-pt.
maximum): 2 (no statistical
analysis performed)
(Continued on following page)
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Publication: J Hosp Infect










Time period: not reported
Population/sample:
asymptomatic antenatal
patients, randomized to 2
groups of 96 each
Comparator: midstream urine
collection after cleansing
with sterile saline and sterile
gauze
Study bias: lower-than-
expected rate of significant
bacteriuria
Description: Sterile packs were used for
all specimens. Noncleansing patients
were instructed in the use of the pack
only. Cleansing patients received the
same information but additionally
were asked to clean the genital area
with sterile gauze swabs soaked in
sterile normal saline and used with a
single backwards stroke before finally
drying the area with another sterile
gauze swab.
Duration: not reported
Training: infection control nurse
provided training to antenatal nurses;
nurses provided detailed instructions
to patients










Type of findings: comparison of culture
results
Findings/effect size:
1. No significant difference in
distributions of colony count results
(P  0.1 by 
2) was found.
2. The only significant difference in
microscopic findings (50 epithelial
cells) was found with 12 individuals
in the noncleansing group and 4 in
the cleansing group (P  0.017); no
other differences for WBC or RBC
were found.
Statistical significance/tests: chi-square
test, Fisher’s exact test
Results/conclusion biases: results may
apply only to ambulatory
antenatal patients
Total quality rating (10-pt.
maximum): 8, good
Total for study (3-pt.
maximum): 2 (small sample
size)
Total for practice (2-pt. maximum): 2 Total for outcome
measures (2-pt.
maximum): 2
Total for results/findings (3-pt.
maximum): 2 (restricted patient
population)




















Time period: not reported
Population/sample:
convenience sample of 100
pregnant, low-income teens
10–19 yr; exclusions were
patients with UTI or a UT
abnormality and patients




Study bias: potential selection
bias
Description: Each subject gave 2 urine
samples during consecutive urinations
in 1 routine prenatal visit; the first was
by midstream collection, the second by
clean-catch collection. Urine samples
were refrigerated immediately after
collection, plated within 5 h of
collection, and cultured by routine
microbiological techniques.
Duration: not reported
Training: patients were given verbal
instructions by nurses.
Staff/other resources: nursing
Cost: a potential cost savings of $97,560/
yr if clean-catch practices were stopped
Description: Significant
bacteriuria was defined




were analyzed for mean
differences in colony




Type of findings: comparative
differences in the numbers and
types of microorganisms
Findings/effect size: Bacteriologic results
were similar for urine specimens





Results/conclusion biases: results may
not be applicable to other patient
populations
Total quality rating (10-pt.
maximum): 8, good
Total for study (3-pt.
maximum): 2 (selection
bias)
Total for practice (2-pt. maximum): 2 Total for outcome
measures (2-pt.
maximum): 2
Total for results/findings (3-pt.
maximum): 2 (restricted definition
of significant growth)




















Time period: April 2010–April
2011
Population/sample:
convenience sample of 113
pregnant women who had







sample used as reference
test.
Study bias: sample size too
small to detect some
differences in collection
technique
Description: 3 methods of collection were
compared for differences in Gram
stain, leukocyte, esterase and nitrate
dip stick, and culture results.
Duration: 12 mo
Training: oral and written sampling
instructions were provided to each
patient.





(defined as no growth
or the growth of only
skin flora), undefined
(growth of 104 CFU/
ml of 1 uropathogen),
or positive (the presence
of 1 uropathogen with a








Type of findings: comparison
Findings/effect size: Mainly low numbers
of Gram-positive rods were more
likely to be present in Gram stains
of midstream samples than in
clean-catch samples (77.7%
compared with 66.7%; P  0.022).
Morning samples showed more
mixed growth than midstream
samples (6.2% compared with
0.9%; P  0.050). No consistency
in quantity of contaminants was
found in midstream samples
compared with morning and clean-
catch samples. No differences were
found between the other endpoints
in all 3 urine samples (P  0.05).
The study could detect an odds
ratio of 2.0 for differences in urine-
sampling methods with 80% power
and 5% significance for most
endpoints.
Statistical significance/tests: Fleiss-
Cohen’s weighted K statistic, odds
ratios, generalized score test
Results/conclusion biases: study not
appropriately powered for all
measures, nearly all samples were
contaminated
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Total quality rating (10-pt.
maximum): 7, fair
Total for study (3-pt.
maximum): 2 (sample size)





Total for results/findings (3-pt.
maximum): 2 (nearly 100% of
samples yielded contaminants)
Authors: Walter and Knopp
(41)

















Funding: supported by a
















who presented to the
Emergency Department
triage nurse with 1 or more
symptoms that could be
attributed to a UTI.
Comparator: catheterized
urine sample
Study bias: ED patients only
Description: Each patient spread her
labia, prepped her periurethral area by
wiping 3 povidone-iodine-soaked 4-
by 4-in. gauzes in an anterior-to-
posterior direction, and spontaneously
voided an midstream clean-catch urine
sample. Then, the patient was
immediately sterilely prepped with
povidone-iodine and catheterized by a
nurse using a Davol single-use female
catheterization kit.
Duration: 7 mo
Training: Patients received standardized
verbal instructions from a nurse on the
method for MSCC urine collection.







esterase and nitrites were
reported as positive or
negative. WBC were
reported as the actual no.
per HPF. Microscopic
bacteriuria was reported
as 0 if absent, 1 for 1 to
10 bacteria/HPF, 2 for
10 to 100 bacteria/HPF, 3
 for bacteria that were
innumerable but loosely
packed in each HPF, and
4 for bacteria that were
innumerable and tightly
packed in each HPF.
A culture-proven UTI
was defined as more
than 10,000 colonies of
at least a single species/
ml of catheterized urine.
Recording method: not
reported
Type of findings: comparison
Findings/effect size: Of the 105 patients,
42 (40%) had a culture-proven
UTIs. The concordance rates
between MSCC and CATH urine
cultures, nitrites, leukocyte
esterase, significant microscopic
bacteriuria, and pyuria were 96%,
94%, 93%, 90%, and 90%,
respectively. There were no
statistically significant differences
between MSCC and catheterized
specimens for sensitivities,
specificities, or positive or negative





test, Fischer’s exact test, and power
analysis. Two-tailed statistical tests
were performed.
Results/conclusion biases: Findings were
limited to ambulatory women who
have 1 or more symptoms
compatible with a UTI and were
specifically instructed in the
proper technique of MSCC urine
sampling.
Total quality rating (10-pt.
maximum): 8, good
Total for study (3-pt.
maximum): 2 (ED patients
only)





Total for results/findings (3-pt.
maximum): 3
Authors: Lemieux and St.-
Martin (45)




Bacteriuria in the Female
Patient
Yr: 1968










Funding: supported in part





Time period: not reported
Population/sample: 3 groups of
patients were studied.
Group 1 consisted of 53
healthy student nurses
(aged 18 to 23 yr; mean, 19
yr) having a first morning
cleanly voided midstream
specimen collected. Group
2 consisted of 29 female
patients admitted to a
general medical female
ward service (aged 21 to 53
yr; mean, 42 yr) with both
clean-void and catheterized
urine specimens collected at
the same time. Group 3
consisted of 27 female
patients (aged 24 to 54 yr;
mean, 43 yr) admitted to
either a semiprivate or
general medical ward. Both
cleanly voided and
catheterized specimens were
collected at the same time.
Comparator: not reported
Study bias: none noted
Description: All specimens were collected in
the same room by the same 2 nurses.
Both the nurses and patients wore sterile
rubber gloves during the entire
procedure of urine collection. The
perineum was carefully scrubbed with
green soap for 2 to 3 min. The labia
majora were then separated, and the
vulva was washed with green soap, with
a fresh cotton swab used after each
downward stroke. The same maneuver
was repeated with an aqueous solution
of Zephiran (benzalkonium; 1:1,000).
The subjects were then instructed to void
after separating the labia majora. After
the stream was well started, a sterile
screw-cap jar was placed into the path of
the stream and a small sample of urine
collected. Subjects from whom paired
specimens were obtained were told to
stop voiding as soon as the cleanly
voided specimen was obtained. A sterile
rubber French no. 8 catheter lubricated
with a small amt of sterile lubricant was
then inserted into the urethra, and a final
specimen was collected in another
screw-cap jar. The specimens were taken
immediately to the laboratory, where
they were processed for bacterial counts,
routine bacterial identification, and
Gram staining.
Description: Specimens







Type of findings: comparative colony
counts
Findings/effect size: In group 1, the
cleanly voided urine samples
contained no bacteria after 48 h in
46 (87%) of the 53 subjects. In
group 2, the incidence of sterile
cleanly voided urine samples was
also quite high (69%), while not a
single catheterized specimen
showed bacterial growth after 48
h. In group 3, a very high degree of
correlation was found between
cleanly voided and catheter
specimens with regard to both the
type of organism and the bacterial
counts
Statistical significance/tests: not reported
Results/conclusion biases: not reported
Duration: not reported
Training: 2 graduate nurses were trained
to collect both cleanly voided and
catheter specimens.
Staff/other resources: not reported
Cost: not reported
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Total quality rating (10-pt.
maximum): 6, fair









Total for results/findings (3-pt.
maximum): 2 (no statistical
analysis)
Authors: Immergut et al.
(44)
















Study bias: none noted
Description: Patients were asked to
urinate in private without any prepn.
They collected the urine at any time
during voiding in an unsterile
disposable plastic cup. The specimens
were immediately cultured on Uricult
media by dipping the slides into the
plastic cups. Routine chemical and
microscopic analysis of the urine was
performed on each specimen. A
cystoscopic examination was
performed with an instrument which
had been soaked for at least 10 min in
Cidex solution and then rinsed in
sterile water. Urine specimens
obtained through the cystoscope were
similarly cultured on Uricult slides.
Duration: not reported
Training: not reported










Type of findings: comparison
Findings/effect size: 91.5% of the
cultures were negative by either
method of collection. 3.2% of the
voided specimens showed Gram-
negative rods, which were identical
to results of specimens obtained
during cystoscopy. 5.3% of
patients had cultures with
50,000 CFU/ml of a Gram-
negative rod in their voided
specimens; their specimens
obtained during cystoscopy were
negative.
Statistical significance/tests: not reported
Results/conclusion biases: not reported
Total quality rating (10-pt.
maximum): 6, fair









Total for results/findings (3-pt.
maximum): 1 (no description of
types of organisms recovered. No
statistical analysis performed)
a MSCC, midstream clean-catch collection; CATH, catheterization; HPF, high-power field.
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TABLE A3 Evidence summary table for contamination and diagnostic accuracy of urine collected from mena
Bibliographic information Total for study Practice Outcome measures Results/findings
Authors: Lipsky et al. (46)
Title: Is the Clean-Catch Midstream Void
Procedure Necessary for Obtaining
Urine Culture Specimens from Men?
Yr: 1984
Publication: Am J Med
Affiliations: Departments of Medicine,
Laboratory Medicine, and Urology,
University of Washington School of




Funding: supported in part by the Health
Services Research and Development
Affiliation Program, Seattle VA
Medical Center
Design: group randomized control
study




Population/sample: total of 308
paired specimens collected
from 254 male patients.
Comparator: midstream urine
without cleansing
Study bias: patient selection
restricted to urology clinic
patients
Description: Subjects were directed to
collect paired voided urine
specimens for culture. Those
whose Social Security numbers
ended in an even digit were
instructed to cleanse their glans
penis with a povidone-iodine pad
prior to voiding. Persons with odd
Social Security numbers served as
noncleansed control subjects.
Patients in both groups collected
10 to 20 ml of “initial” and
“midstream” specimens by passing
the first part of the voided urine
into a sterile cup, discarding the
next 100 to 200 ml of urine into
the urinal, and then collecting a
second aliquot of urine in another
sterile container. All specimens
were immediately refrigerated at
4°C and delivered within 4 h to the
clinical microbiology laboratory
for Gram staining and
semiquantitative culture.




streptococci or enterococci. All
other organisms were identified to
the species level.
Duration: 7 mo
Training: A graphic instructional sign
displaying the clean-void
procedure was posted in the
bathroom where the samples were
collected.
Staff/other resources: A technician
was available to patients needing
assistance.
Cost: not reported
Description: A “positive” culture
was defined as one with
growth of 10,000 or more
CFU/ml of a single or
predominant organism.
Specimens growing 1,000
CFU/ml of a single or
predominant organism were
called “indeterminate.” Those
with 1,000 or more CFU/ml
with 2 or more colonial types
and with no predominant
organism were defined as
“contaminated.” Specimens





Type of findings: comparison
Findings/effect size: The rates
of true bacteriuria and
contamination were






different (P  0.05) in
circumcised and
uncircumcised patients,
or in those who
cleansed their meatus
and those who did not.
Contamination but not
bacteriuria rates were







by the standard chi-









Total quality rating (10-pt. maximum): 9,
good
Total for study (3-pt. maximum):
2 (only urology clinic patients
included)
Total for practice (2-pt. maximum): 2 Total for outcome measures (2-
pt. maximum): 2
Total for results/findings (3-
pt. maximum): 3
Authors: Lipsky et al. (47)
Title: Diagnosis of Bacteriuria in Men:
Specimen Collection and Culture
Interpretation
Yr: 1987
Publication: J Infect Dis
Affiliations: Departments of Medicine
and Urology, University of
Washington School of Medicine, and
Medical and Surgical Services, Seattle
VA Medical Center, Seattle, WA
Funding: not reported
Design: observational study
Facility/setting: VA medical center
Time period: not reported
Population/sample: 66
ambulatory or hospitalized
male patients who had acute
dysuria or other irritative
genitourinary symptoms, were
known to have bacteriuria, or
were scheduled for a urologic
procedure. Individuals were
excluded because of an
inability to void at will, use of
any type of internal or external
device for urine collection,
massive obesity, previous lower
abdominal surgery or radiation
therapy, known or suspected
bladder neoplasm, or any
coagulation disorder.
Comparator: urine collected by
suprapubic aspiration
Study bias: subjects were not
randomly selected.
Description: Specimens were
collected in the following order:
suprapubic aspiration (10 ml),
uncleansed first void (the first 10
ml was voided without prior
cleansing of the urethral meatus),
clean-catch midstream void (10 ml
was voided after cleansing the
urethral meatus with povidone-
iodine and voiding 100 ml), and
urethral catheterization (10 ml).
At least 1 bladder (suprapubic
aspiration or urethral
catheterization) and 1 voided
(uncleansed first void or clean-
catch midstream void) specimen
were collected from every subject.
Duration: not reported
Training: not reported








examined after incubation for
18–24 h. Isolates from plates
with fewer than 3 different
colonial types were identified
to the species level. Urine
leukocytes were quantitated
(in cells/mm3 of
uncentrifuged urine) in a
hemacytometer. Sensitivity,
specificity, positive predictive
value, and negative predictive
value were calculated for




specimens used as the
reference standard.
Recording method: not reported
Type of findings: comparison
Findings/effect size: Bladder
bacteriuria was found in















urine was the growth of














(Continued on following page)
Urine Culture Preanalytics
January 2016 Volume 29 Number 1 cmr.asm.org 135Clinical Microbiology Reviews
TABLE A3 (Continued)




specimens was tested with
use of a weighted k






group of mostly elderly
ambulatory men with
various genitourinary
disorders. When a positive
culture is used for
screening or in
populations with a low
incidence of bacteriuria,
the predictive value of a
positive culture will be less
than in this study.
Total quality rating (10-pt. maximum): 7,
fair
Total for study (3-pt.
maximum): 2 (selection
bias)
Total for practice (2-pt. maximum): 2 Total for outcome measures (2-
pt. maximum): 1 (recording
method not reported)
Total for results/findings (3-
pt. maximum): 2 (higher
pretest probability than
found in general patient
population)
Authors: Deresinski and Perkash (48)
Title: Urinary Tract Infections in Male
Spinal Cord Injured Patients. Part
One: Bacteriologic Diagnosis
Yr: 1985
Publication: J. Am. Paraplegia Soc.
Affiliations: Spinal Cord Injury Service
VA and Stanford University Medical






Time period: not reported
Population/sample: 71 paired
samples were obtained
from 53 male spinal cord
injury patients, 28
paraplegics (22 complete),




Study bias: none noted
Description: 71 paired samples of
urine, obtained by collection of a
cleanly voided specimen and by
SPA of the bladder, were obtained
from 53 male spinal cord injury
patients who were free of
indwelling catheters. A direct
comparison of the no. of CFU of




Staff/other resources: not reported
Cost: not reported
Description: Quantitative urine
cultures were performed on
all collected samples. Bacteria
were identified by routine
biochemical methods.




1. A direct comparison of
the no. of CFU of
bacteria within the
paired specimens
indicated that a single
voided specimen was
adequate in 63 of 71
(88.7 %) samples. With
a threshold of 10,000
CFU/ml of urine
obtained by SPA, the
presence of at least
10,000 CFU/ml of
voided urine provided a
sensitivity and specificity
of 100%.
2. In patients with colony
counts of 100 to 10,000




urine is most likely to be







Total quality rating (10-pt. maximum): 5,
fair
Total for study (3-pt.
maximum): 2 (the total for
the study population is not
sufficiently described)
Total for practice (2-pt. maximum): 1
(poor description of practice)
Total for outcome measures (2-
pt. maximum): 1 (recording
method not described)
Total for results/findings (3-
pt. maximum): 1 (small
no. of patients studied.
Data do not permit
effect size calculation)
a SPA, suprapubic aspiration.
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TABLE A4 Evidence summary table for contamination and diagnostic accuracy of urine collected from childrena
Bibliographic information Total for study Practice Outcome measures Results/findings
Authors: Karacan et al. (53)
Title: Evaluation of Urine
Collection Methods for














Time period: not reported
Population/sample: 1,067 children,
88 younger than 1 mo, 126
between 1 and 6 mo, 318
between 7 and 24 mo, and 535
older than 24 mo of age. There
were 521 (48.9%) girls. Of these
1,067 children, 951 (89.1%)
were admitted to the outpatient
clinic and 116 (10.9%) were
admitted to the inpatient clinic.
Comparator: none
Study bias: none noted
Description: 4 methods of urine collection
were studied: SPA, CCU, CATH, and
UB.
Duration: 2 mo
Training: Nurses trained parents on UB
collection. Hospital personnel were
trained on proper collection of SPA
and CATH specimens.
Staff/other resources: not reported
Cost: not reported
Description: The specimens collected
by type were divided according to
age group. The no. of specimens
yielding significant pathogens and
the no. of contaminated
specimens were calculated.
Semiquantitative cultures were
performed by routine laboratory
methods. A positive urine culture
was defined as the growth of a
single pathogen of more than 105
CFU/ml in UB and CCU
specimens, 104 CFU/ml in urine
specimens obtained by CATH,
and any no. of colonies in a
sample obtained by SPA. Urine
cultures interpreted as
“contaminated” by the laboratory
were considered to be
contaminated.
Recording method: not reported
Type of findings: observational
Findings/effect size: 617 subjects
(57.8%) had negative culture
results, 145 (13.6%) had
positive culture results, and
305 (28.6%) had evidence of
bacterial contamination.
CCU and CATH specimens
showed a contamination rate
of 14.3%. However, urethral
catheterization was
performed in only a small no.
of subjects (n  7). SPA was
also used in a small no. of
subjects (n  11), and the
contamination rate for SPA
was 9.1% (1/11). The
contamination rate for sterile
UB was 43.9%, significantly
higher than rates for the
other methods (P  0.001).
Statistical significance/tests: The
data were analyzed using the
Statistical Package of Social
Sciences for Windows,
version 10.0 (SPSS Inc.,
Chicago, IL, USA) program.
Pearson’s 2 and Fisher’s exact
tests were used to compare
differences between groups. A
P of 0.05 was considered
significant.
Results/conclusion biases: Parental
collection of UB specimens
may have contributed to a
high contamination rate.
Total quality rating (10-pt.
maximum): 6, fair
Total for study (3-pt. maximum):
2 (not a controlled study)
Total for practice (2-pt. maximum): 1
(poor description of practice as relates
to no. of different specimen types
collected)
Total for outcome measures (2-pt.
maximum): 1 (recording method
not described)
Total for results/findings (3-pt.
maximum): 2 (insufficient
no. of SPA and CATH
specimens included in data
analysis)
Authors: Alam et al. (49)




















Time period: not reported
Population/sample: Children aged
up to 3 yr without known UTI
had urine collected by 3
different methods used
consecutively, namely, clean-
catch, cotton wool sanitary pad,
and urine bag. 534 urine
samples were obtained from 191
children. There were 124 boys
(65%). The median age was 2
mo (1 day–36 mo).
Comparator: intersubject
Study bias: order of specimen
collection not defined
Description: 3 urine samples collected
after perineal cleaning with soap and
water (all 3 collected on same day or
next day if required, with the order of
collection at the nurses’ discretion).
The 1st was a clean-catch specimen, the
2nd was collected in a cotton pad
(either sterile Newcastle or commercial
sanitary pads) and aspiration with a
syringe. The 3rd was collected in a
Hollister urine bag taped to the infant.
Samples were held in a refrigerator,
transferred to sterile coded tubes, and
plated within 20 min of receipt by the
laboratory. Cultures were interpreted
as 105 or 105 CFU/ml. Also,
microscopy was performed on
uncentrifuged urine.
Duration: 2 mo
Training: parents instructed by nursing on
proper urine collection.
Staff/other resources: not reported
Cost: cost of pads described
Description: The percentage of urine
samples contaminated by each
collection method was based on a
quantity of 105 or 105 CFU/
ml, organism type, and agreement
between sample types. Phase-
contrast urine microscopy results
were correlated with culture
results.
Recording method: not reported
Type of findings: descriptive,
comparative
Findings/effect size: Results from
175 patients showed similar
contamination rates for pads
and bags but lower rates for
clean-catch specimens (P 
0.01). Kappa analyses showed
fair agreement between
clean-catch specimens and
those collected in pads/bags.
The difference between sterile
pads and sanitary pads was
not significant. No significant





agreement between the tests
calculated using kappa
statistics. More than 40%
agreement was regarded as a
good level of agreement. The
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Total quality rating (10-pt.
maximum): 8, good
Total for study (3-pt. maximum):
3
Total for practice (2-pt. maximum): 2 Total for outcome measures (2-pt.
maximum): 1 (recording method
not described)
Total for results/findings (3-pt.
maximum): 2 (limited patient
population)
Authors: Macfarlane et al.
(54)














Time period: not reported
Population/sample:
1. 88 inpatients, all below 2 yr of
age, were included. 56 UCP
samples were reliably
obtained; the remaining 32
samples failed for a variety of
reasons and were excluded.
2. 34 children in the same age
range had urine bag collection
done over the preceding 9 mo.
3. 240 clean-catch samples were




Study bias: nonrandom, unequal
sample sizes, no standard
reference method
Description:
1. The UCP was placed inside the front
of the child’s nappy; the child’s nurse
checked the pad every 15–20 min,
removed it when wet, and aspirated
urine from it using a 20-ml syringe.
Fecally soiled pads were discarded.
2. Urine from 34 children in the same
age range and ward setting that had
bag urine collection done over the
preceding 9 mo was similarly tested.
Duration: 3 mo
Training: not reported
Staff/other resources: not reported
Cost: not reported
Description: colony counts (CFU/
ml) across all sample types.
Recording method: not reported
Type of findings:
observational/comparative
Findings/effect size: UCPs resulted
in an unhelpfully high rate of
contamination (65%) similar
to that for bag samples
(68%). Only 27% of clean-
catch urine samples were
contaminated. Sterile urine
or urine with a low (105
CFU/ml) mixed bacterial
count is probably sufficient in
most cases to rule out UTI,
whereas a sample
contaminated by a heavy
mixed growth may hide
infection. Such samples may
need to be repeated. Applying
this principle to our series,
the authors found that 14
(27%) of 52 pad samples, 11
(32%) of 34 bag samples, but
only 29 (12%) of 240 clean-





Total quality rating (10-pt.
maximum): 5, fair
Total for study (3-pt. maximum):
1 (different patient populations
and sizes, no reference
standard)
Total for practice (2-pt. maximum): 1
(limited practice description)
Total for outcome measures (2-pt.
maximum): 1 (recording method
not reported)
Total for results/findings (3-pt.
maximum): 2 (no statistical
analysis)
















Time period: not reported
Population/sample: 2 urine
samples, collected from 45
infants aged 1–23 mo, 1 with a
sterile bag and 1 from a nongel
diaper
Comparator: bag vs diaper
Study bias: only inpatients
included in study, small sample
size
Description: 2 consecutive urine samples
were collected from 45 infants who
were 1–23 mo old: 1 from a sterile
urine bag and 1 from a nongel diaper.
Diapers older than 4 h and containing
feces were excluded. WBC and RBC
evaluations were performed using
microscopy. All specimens were




Staff/other resources: not reported
Cost: not reported
Description: semiquantitative culture
with standard definitions for
contamination and significance
(105 CFU/ml)
Recording method: not reported
Type of findings: comparative
Findings/effect size: 37 of 45 urine
cultures showed complete
agreement between the 2
collection techniques (22
sterile urine samples, 9 mixed
cultures, 6 with significant
growth). 7 infants had mixed
growth from bag specimens
but sterile culture results
from diaper specimens.1
infant had 105 CFU/ml of
different organisms in the bag






Total quality rating (10-pt.
maximum): 7, fair
Total for study (3-pt. maximum):
2 (small sample size)
Total for practice (2-pt. maximum): 2 Total for outcome measures (2-pt.
maximum): 1 (recording method
not reported)
Total for results/findings (3-pt.
maximum): 2 (no statistical
analysis)
(Continued on following page)
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Authors: Vaillancourt et al.
(50)























Design: randomized control study
Facility/setting: teaching
hospital/ED
Time period: 1 November 2004–1
October 2005
Population/sample: All toilet-
trained children who were
between the ages of 2 and 18 yr
and had a midstream urine
sample requested were eligible.
Comparator: those whose parents
consented were cluster
randomized by week to either
cleaning or not cleaning the
perineum with soap
Study bias: only patients with a
positive urinalysis were cultured
Description: At the beginning of each wk
throughout the study period, the
method for collecting a urine specimen
for all children who presented to the
ED during that wk was randomly
assigned by the study investigators.
During the cleaning wk, the child was
given liquid soap, several gauze pads, a
sterile urine collection container, and
an instruction sheet. The child and/or
the parent was instructed to spread the
labia (for girls) or retract the foreskin
(for noncircumcised boys) and to clean
the urethral meatus and perineum with
gauze and liquid soap twice (wiping
from front to rear in girls). The child
was then to urinate into the toilet and,
midway through urination, to collect
the urine into the sterile container.
During the noncleansing wk, the child
was given neither a sterile urine
collection container nor an instruction
sheet. Urine specimens were sent to the
microbiology laboratory in sterile
containers. Standard quantitative
culture was performed by a laboratory
technologist.
Duration: 1 yr
Training: Multiple posters were then
displayed to inform the ED staff as to
whether it was a cleansing or
noncleansing wk. Verbal and written
instructions for obtaining the urine
specimen were given to the child and
parent(s).
Staff/other resources: not reported
Cost: not reported
Description: The risk for a
contaminated urine culture
(defined as growth of 105 CFU/
ml of a single organism or a mix
of 2 organisms) and the risk for
a positive urinalysis result
(defined as a positive leukocyte
esterase and/or nitrites on a
dipstick or 5 WBC/HPF upon
standard microscopic
examination) were analyzed by
intention to treat. The authors
estimated the no. of children
needed to detect a clinically
important difference of 20%,
based on an alpha value of 0.05
and a power of 80%.
Recording method: A questionnaire
was administered with the urine
collection instructions to the
parent of each participating child
to document the age, gender,
circumcision status (for boys),
antibiotic use in the previous 2
wk, and previous renal problems
(other than a previous UTI).
Type of findings: comparative
Findings/effect size: A total of 350
children were enrolled. The
overall prevalence of UTIs
was 7%. The rate of
contamination in the
cleaning group was 14 (7.8%)
of 179 vs 41 (23.9%) of 171 in
the noncleansing group.
Children who were randomly
assigned to cleansing were
less likely to have a positive
urinalysis (37 of 179 [20.6%])
than those in the
noncleansing group (63 of
171 [36.8%]).
Statistical significance/tests: RR
and their 95% CI for
contamination and for a
positive urinalysis were
calculated using SPSS 11.0
(SPSS, Chicago, IL). The chi-
square test was used to test
for a difference in the culture
results between the cleansing
and noncleansing groups
among samples with a
positive urinalysis result.
Because the intervention was
randomized by wk rather
than by individual patient, a
GLIMMIX was also used to
account for potential within-
wk clustering of outcome
results and to adjust for
potential baseline imbalances
in gender, age, and history of
renal problems. The
interaction terms for
treatment by gender and age
were also included in the
GLIMMIX.
Results/conclusion biases: The lack
of a reference method makes
assignation of true positives
(infected) difficult.
Total quality rating (10-pt.
maximum): 9, good
Total for study (3-pt. maximum):
3
Total for practice (2-pt. maximum): 2 Total for outcome measures (2-pt.
maximum): 2
Total for results/findings (3-pt.
maximum): 2 (lack of a
reference standard)

































Time period: 1 February–30 April
2008
Population/sample: urine samples
from 599 patients under 24 mo





Study bias: retrospective study
(precise clinical indications for
why/how urine was collected
were not available)
Description: Microscopy and culture
results from all urine specimens were
retrieved from the hospital’s
microbiology database. The first urine
specimen collected from each child in
this time period was included for
analysis. Urine culture results from
CCU, SPA, CATH, and SUB collection
were analyzed. Patient age, gender,
location, and method of collection
were gathered from the microbiology
database. For specimens for which the
method of collection was by SPA,
CCU, or CATH, the medical history
was reviewed for documentation of a
past history of UTI, urogenital
abnormality, and antibiotic use at time
of urine specimen collection.
Contamination rates were defined by
the laboratory as growth of 2 or more
organisms at a concn of 101 CFU/ml
for SPA and CCU samples and 103
CFU/ml in CCU and SUB samples.
Duration: 3 mo
Training: Histories were reviewed by 2
primary investigators using a
standardized form that was piloted on
10 histories, for which there was no
disagreements in data extraction.
Staff/other resources: not reported
Description: The primary outcome
measure was the contamination
rate for each urine specimen
collection method. Authors also
sought to adjust for possible
confounding factors by
investigating the effect of age,
gender, location, history of UTIs
and urogenital abnormality, and
antibiotic use at time of urine
specimen collection.
Recording method: lab database,
standardized form for patient
histories
Type of findings: observational
Findings/effect size:
1. The age range of children was
0–23 mo, with a mean age of 7
mo. Overall, most urine
specimens were obtained by
CCU collection (34%),
followed by CATH and SPA.
ED collections were by CCU
collection (39%), CATH
(15%), SPA (16%), SUB
collection (0%), and
unknown means of collection
(30%), whereas inpatient
collections were by CCU
collection (19%), CATH
(23%), SPA (11%), SUB
(4%), and unknown means of
collection (42%).
2. Contamination rates were
26% in CCU vs 12% in CATH
specimens (OR, 0.4; 95% CI,
0.2–0.8) and 1% in SPA
specimens (OR 0.03; 95% CI,
0.0–0.3). The few bag
specimen samples showed a
high rate of contamination
(46%), and urine collected by
an unspecified method had a
contamination rate of 20%.
(Continued on following page)
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Funding: not reported Cost: not reported 3. 369 medical records were
available for review. 5% of
patients had had prior UTIs,
14% were receiving
antibiotics when the specimen
had been obtained, and 11%
had a known urogenital
abnormality. Only antibiotic
use at the time of urine
collection was associated with
a lower contamination rate
(OR, 0.18; 95% CI,
0.04–0.75). Results by
multivariable logistic
regression when adjusted for
age, gender, patient location,
and antibiotic use were
similar.
Statistical significance/tests:
Logistic regression was used
to compare contamination
rates between collection
methods, using CCU as the
comparator for ORs.
Statistical calculations were
performed using Stata 11.0
(Stata Corp., College Station,
TX).
Results/conclusion biases: The use
of urine dipstick tests as a
method of prescreening
specimens by the treating
clinician prior to being sent
for culture may have
introduced bias.
Total quality rating (10-pt.
maximum): 7, fair
Total for study (3-pt. maximum):
1 (retrospective study of
laboratory data)
Total for practice (2-pt. maximum): 2 Total for outcome measures (2-pt.
maximum): 2
Total for results/findings (3-pt.
maximum): 2 (prescreening of
specimens by urine dipstick)
Authors: Morton and
Lawande (57)


























Facility/setting: outpatient clinic in
a pediatric children’s teaching
hospital
Time period: not reported
Population/sample: SPA urine was
collected from 287 children; 51
of these also had an MSU
specimen collected. An
additional 124 children had
only MSU collected.
Comparator: SPA urine
Study bias: all SPA collections
performed by a single
individual
Description: SPA sample collection was by
using a 19-gauge needle; the skin was
cleaned with iodophor, and a 2nd
attempt was made if the 1st aspiration
failed. MSU collection was performed
under supervision after cleansing of the
external genitalia. All specimens were
refrigerated prior to being processed
for semiquantitative culture. Samples
were also processed for urine
microscopy.
Duration: not reported
Training: SPA was performed by a trained
physician; mothers were instructed on
collection of MSU.
Staff/other resources: not reported
Cost: not reported
Description:
1. No. of bacteria in SPA vs MSU
samples were counted.
2. No. of contaminated MSU
specimens from patients with
sterile SPA specimens were
counted.
3. Culture and microscopy results
were compared for all specimens




1. The initial attempt at SPA was
successful in 260/287 patients
without complication and was
easy to perform.
2. MSU collection was often
difficult to perform and took
up to 2 h.
3. In 51 patients with paired SPA
and MSU specimens, there
were no false-positive or false-
negative diagnoses made with
the MSU samples.
4. A high no. of contaminated
specimens was found among
MSU samples collected by






Total quality rating (10-pt.
maximum): 6, fair
Total for study (3-pt. maximum):
1 (total for study setting may
not be generalizable; SPA
collection by single individual)
Total for practice (2-pt. maximum): 2 Total for outcome measures (2-pt.
maximum): 1 (recording method
not reported)
Total for results/findings (3-pt.
maximum): 2 (no statistical
analysis)
(Continued on following page)
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Authors: Pylkkanen et al.
(58)




















Time period: not reported
Population/sample: 477 patients
seen at an outpatient clinic were
included in the study.
Comparator: patients on whom
SPA was performed
Study bias: outpatients only
Description:
1. Urine was collected by SPA.
2. CVU was collected from infants with
urine collection bags.
3. Midstream CVU was collected from
children after cleansing of genitalia
with 0.05% chlorhexidine solution.
All specimens were examined by
microscopy. All specimens were
processed on Uricult dipslides. SPA




Staff/other resources: not reported
Cost: not reported
Description: Cell counts were
classified as 10, 11–199, or
200/mm3. Bacterial counts were
classified as nil, scanty, or
numerous by microscopy and as
103, 104, or 105 by
quantitative culture. Urine
collected by SPA was cultured on
both Uricult and blood agar
plates. A patient was considered
infected when both cultures
showed growth.
Recording method: not reported




bacterial cell counts, or 105
CFU/ml in culture for 59%,
42%, and 81% of infected (as
diagnosed by SPA)
symptomatic patients.
Diagnostic accuracies of these




lower. None of the indices
gave sufficient sensitivity or





Total quality rating (10-pt.
maximum): 7, fair
Total for study (3-pt. maximum):
2 (may not be generalizable to
inpatient patient populations)
Total for practice (2-pt. maximum): 1 (use
of Uricult medium may impact quality
of culture results)
Total for outcome measures (2-pt.
maximum): 1 (recording method
not reported)
Total for results/findings (3-pt.
maximum): 3
















Time period: not reported
Population/sample: 120 specimens
from infants (0–12 mo) and
children (3–12 yr)
Comparator: SPA urine vs cleanly
voided urine
Study bias: small sample size
Description: Percutaneous SPA was
carried out after the suprapubic area
was cleansed with alcohol and iodine.
The urine was gently aspirated in a 5-
or 10-ml sterile syringe and the needle
withdrawn. Cleanly voided urine from
infants was collected in a sterile
polyethylene urine bag after previous
proper cleansing of the vulva, preputial
folds, and perineum. Irrigation of the
vulva and prepuce was performed twice
with 5 to 10 ml tepid physiologic saline.
A cleanly voided midstream specimen
was obtained from children after a
thorough cleansing as described above.
Specimens were transported to the




Staff/other resources: not reported
Cost: not reported
Description: Urinary infection was
considered to be present if the
bacterial count was 102 CFU/ml
in SPA urine (true bacteriuria)
and was suspected if the bacterial
count in cleanly voided urine was
105 CFU/ml. Shortly after
collection, the uncentrifuged
urine was also examined for
pyuria, expressed as the leukocyte
count/mm3. Leukocyte counts of
10 cells/mm3 in SPA urine was
considered pathological.
Recording method: not reported
Type of findings: observational
Findings/effect size: In infants, the
suspicion of infection from
cleanly voided counts of
105 CFU/ml could be
excluded by a finding of
normal SPA urine for 27
babies. 4 babies had infection
in their SPA urine despite
having only slight or
moderate bacteriuria in their
cleanly voided urine. 4
patients suspected of having
an infection from their
cleanly voided urine proved
to be free of infection by
examination of the SPA
urine, whereas 4 patients with
true bacteriuria had a low
bacterial count in voided
urine. Misleading
information about bladder
urine bacteriuria was thus
obtained from bacterial
culture of cleanly voided





may have been influenced by
a small sample size.
Total quality rating (10-pt.
maximum): 7, fair
Total for study (3-pt. maximum):
2 (small sample size)
Total for practice (2-pt. maximum): 2 Total for outcome measures (2-pt.
maximum): 1 (recording method
not reported)
Total for results/findings (3-pt.
maximum): 2 (no statistical
analysis)
(Continued on following page)
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TABLE A4 (Continued)
Bibliographic information Total for study Practice Outcome measures Results/findings
Authors: Hardy et al. (60)
Title: Comparison of Sterile
Bag, Clean-Catch and
Suprapubic Aspiration












Facility/setting: inpatient ward at a
tertiary hospital
Time period: not reported
Population/sample: 30 inpatients;
age range, 1 day to 3 yr. All were
screened for urinary infections,
with the bag technique being
used for those without bladder
control. If bacterial growth was
obtained from the first bag
specimen, the child was entered
into the formal study. Also
entered were patients whose
condition demanded immediate
antimicrobial therapy, for
whom a delay caused by
screening could not be justified.
In the latter group, all 3
specimens were taken without
screening.
Comparator: SPA
Study bias: small sample size
Description: SUB, CCU, and SPA
specimens were obtained. The
perineum and suprapubic regions were
cleansed with sterile swabs moistened
with distilled water before the
specimens were collected. Specimens





Staff/other resources: not reported
Cost: not reported
Description: Bacteria were
quantitated on CLED culture
medium and read after 18 h of
incubation. The white cells were
counted in unstained,
uncentrifuged urine.
Recording method: not reported
Type of findings: observational
Findings/effect size:
1. In SPA specimens, there was
no growth from 26 specimens
and a pure growth of 105
CFU/ml or more organisms
from the remaining 4
specimens. It was assumed
that only these 4 had
significant bacteriuria.
2. Bag and CCU specimens
exhibited a high incidence
(73%) of mixed growth. The
mixed growth occurred from
specimens that were sterile
when taken by SPA.
3. There was agreement between
bag, CCU, and SPA specimens
in only 3 cases of no growth,





may be impacted by small
sample size.
Total quality rating (10-pt.
maximum): 5, fair
Total for study (3-pt. maximum):
1 (small sample size, study
population not well described)
Total for practice (2-pt. maximum): 1
(significant bacteriuria vs
contamination not defined)
Total for outcome measures (2-pt.
maximum): 1 (recording method
not reported)
Total for results/findings (3-pt.
maximum): 2 (no statistical
analysis)
Authors: Ramage et al. (51)





Affiliations: Renal Unit and
Department of
Diagnostic Imaging,










Time period: not reported
Population/sample: 49 pediatric
inpatients of 24 mo for whom
urine culture was indicated
Comparator: SPA
Study bias: parents were involved
in specimen collection process
Description: 58 paired urine cultures
obtained by CCU collection and SPA
were taken from 49 infants, 0–24 mo
old (22/49 male, 45%). Comparison
SPA and CCU collections occurred
during a 48-h period. The urine
obtained was inoculated onto a dipslide
culture plate. The plates were allowed
to drain and then replaced securely
into the container. The specimen was
cultured at 37°C and was interpreted
after a minimum of 16 h. Urine
cultures were defined as positive in the
presence of a pure growth of 105
CFU/ml in those specimens obtained
by CCU collection and as the growth of
any quantity of organism in those
obtained by SPA.
Duration: not reported
Training: Parents were given instruction
by nurses on collection of CCU
specimens.
Staff/other resources: not reported
Cost: not reported
Description: The primary outcome
measure was the presence or
absence of significant bacteriuria
after both CCU collection and
SPA; secondary outcome
measures were the success of SPA
with ultrasound guidance
compared with aspiration without
ultrasound guidance.
Recording method: not reported
Type of findings: comparison
Findings/effect size:
1. Compared to SPA specimens,
CCU specimens showed a
false-positive rate of 5% and a
false-negative rate of 12%,
with a sensitivity of 88.9%
(95% CI, 65.3–98.6) and a
specificity of 95.0% (95% CI,
83.1–99.4).
2. Of 16 cultures in which SPA
and CCU specimens were
positive, the 2 specimens that
were negative by SPA but
positive by CCU collection
(false-positive results)
demonstrated a mixed growth
of 105 CFU/ml. In 2 SPA
specimens demonstrating
significant growth, a pure
growth of 103 CFU/ml was
seen in one CCU culture and a
mixed growth of 103 CFU/ml






Total quality rating (10-pt.
maximum): 8, good
Total for study (3-pt. maximum):
2 (small sample size)
Total for practice (2-pt. maximum): 2 Total for outcome measures (2-pt.
maximum): 1 (recording method
not reported)
Total for results/findings (3-pt.
maximum): 3
(Continued on following page)
LaRocco et al.
142 cmr.asm.org January 2016 Volume 29 Number 1Clinical Microbiology Reviews
TABLE A4 (Continued)
Bibliographic information Total for study Practice Outcome measures Results/findings
Authors: Cohen et al. (61)























Time period: not reported
Population/sample: 38 infants aged
1 to 24 mo who presented to a
pediatric ambulatory
community clinic with fever
Comparator: SPA or bladder
CATH urine samples
Study bias: potential subject
selection bias; small sample size
with inability to consider CATH
and SPA separately (possible
practice confounder)
Description: all infants had urine collected
either by CATH or SPA and by
extraction from a disposable diaper.
The urine was extracted from the
diapers by removing the lining layer of
the diaper under aseptic conditions
using sterile tweezers, and then pushing
the damp fibers into the barrel of a
standard 20-ml disposable syringe from
which the plunger had been removed.
By replacing the plunger and
compressing the fibers, urine was easily
obtained from the diapers. Ultra-
absorbent diapers that contain a gel-
like material were excluded from the
study because extracting urine from
them is difficult and time-consuming.
In addition, diapers contaminated with
feces or those that had been on the
infant for longer than 3 h were
excluded. The urine samples were sent





Staff/other resources: not reported
Cost: not reported
Description: Laboratory technicians
interpreting the urinalysis and
urine cultures were blind to the
patient’s clinical information and
to other laboratory information.
Recording method: not reported
Type of findings: comparative
Findings/effect size: Urinary tract
infection was demonstrated
by SPA or CATH specimen
collection from 5 (13.2%)
infants (4 female and 1 male).
For all 5 children, urine
cultures showed more than
105 CFU/ml of the same
single organism from urine
that had been collected from
both the diapers and the SPA
or CATH specimens
(sensitivity of 100% [5/5])
and specificity of 94% ([31/
33]). A statistical analysis
revealed a wide CI and
estimated the low end to be
55% for sensitivity and 82%
for specificity. These results




not reported) revealed a wide
CI and estimated the low end
to be 55% for sensitivity and
82% for specificity. These




particularly for infants with
positive results, explains why
the confidence limits are
much lower than the
estimated values.
Total quality rating (10-pt.
maximum): 5, fair
Total for study (3-pt. maximum):
1 (SPA and CATH samples not
separated)
Total for practice (2-pt. maximum): 1
(“significant bacteriuria” not defined vs
“contamination”)
Total for outcome measures (2-pt.
maximum): 1 (recording method
not reported)
Total for results/findings (3-pt.
maximum): 2 (results include
very few infants with
significant bacteriuria)




















Time period: not reported
Population/sample: 50 infants aged
0 to 18 mo (mean age, 2.8 mo;
median age, 1.4 mo); inclusion
criteria were a suspicion of UTI
or the presence of neonatal
fever, no antibiotics during
preceding week, and no
anatomic abnormalities or
systemic disease preventing
urine collection by SPA or bag
collection
Comparator: SPA sample
Study bias: none noted
Description: SPA was done first, followed
by bagged urine collection. Specifics
and instructions were not reported for
how procedures were performed; urine
transport was not described, and urine
workup was not described or defined.
Duration: not reported
Training: not reported
Staff/other resources: not reported
Cost: not reported
Description: culture results reported
as pure growth, mixed growth, or
no growth
Recording method:
Type of findings: comparison
Findings/effect size: 7 SPA
specimens exhibited pure
growth of organisms, for a
true UTI rate of 14%. 14
bagged urine specimens
exhibited pure growth (13 of
which were falsely positive, as
SPA was negative), 23
exhibited mixed growth, and
1 that exhibited mixed
growth also had a positive
SPA result; the remaining
mixed-growth specimens
were negative by SPA. The
bagged-urine contamination
rate was 62%. 30/50 bagged
urine samples gave a false-
positive result as either pure
or mixed growth. Negative
bagged urine samples were






Total quality rating (10-pt.
maximum): 8, good
Total for study (3-pt. maximum):
3
Total for practice (2-pt. maximum): 1
(microbiological methods not
described)
Total for outcome measures (2-pt.
maximum): 1 (recording method
not described)
Total for results/findings (3-pt.
maximum): 3
(Continued on following page)
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Time period: October 2004–June
2007
Population/sample: 192 non-toilet-
trained children of 3 yr of age
from 2 emergency departments
(all had fever of unknown
origin on presentation)
Comparator: urine obtained by
CATH
Study bias: The indication for
CATH was left up to the
physician, depending on bag
urinalysis results and the
patient’s clinical and biological
data.
Description: An adhesive urine bag was
placed on the child by a nurse.
Urinalysis was performed, and then
depending on this information, CATH
was performed. Urine culture results
from bag vs catheter-obtained
specimens were assessed, with catheter
culture as the reference.
Duration: 44 mo
Training: nurses trained on
catheterization procedure
Staff/other resources: not reported
Cost: not reported
Description: comparison of bag
cultures and catheter cultures for
making a clinical diagnosis of
UTI. Definitions were as follows:
positive urine culture for bag
specimens, 105 CFU/ml;
positive urine culture for CATH
specimens, 103 CFU/ml (1
species only); polybacterial urine
culture (considered a
contaminated sample), 105 or
103 CFU/ml (depending on
collection method) and 2
species present upon culture;
negative urine culture, all the
other specimens.
Recording method: not reported
Type of findings: comparison
Findings/effect size: A total of 7.5%





obtained specimens led to
either a misdiagnosis or an
impossible diagnosis in 40%





performed using the chi-
square test
Results/conclusion biases: Failure




CATH specimens was also
higher than expected.
Total quality rating (10-pt.
maximum): 7, fair
Total for study (3-pt. maximum):
2 (selective catheterization)
Total for practice (2-pt. maximum): 2 Total for outcome measures (2-pt.
maximum): 1 (recording method
not reported)




a SPA, suprapubic aspiration; CCU, clean-catch urine; CVU, cleanly voided urine; CATH, straight catheterization; SUB, sterile urine bag; UCP, urine collection pad; MSU,
midstream urine; ED, emergency department; HPF, high-power field; RR, relative risks; 95% CI, 95% confidence interval; GLIMMEX, generalized linear mixed model; OR, odds
ratio; CLED, cystine lactose electrolyte-deficient.
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